Document:

Exhibit 10.3

 

LICENSE
AGREEMENT

 

THIS
LICENSE AGREEMENT (“Agreement”) is made and entered into as of this 4th day of
November 2014, between kathy ireland Worldwide, Inc., a California corporation (“Licensor”), and NuGene Inc
(“Licensee”), as follows:

 

WITNESSETH:

 

WHEREAS,
Ms. Kathy Ireland (“Ms. Ireland”)
is an internationally famous woman and designer with a highly favorable public image and strong brand identity; and a strong portfolio
of multiple brands and ambassadors, also with a highly favorable public image and strong brand identity.

 

WHEREAS,
Licensor has the right and authority to license certain registered trademarks and rights to the name, likeness, and visual representation
of Ms. Ireland and such name, likeness, and visual representation being well known and recognized by the general public and associated
in the public mind with Licensor.

 

WHEREAS,
Licensor is the owner, by assignment, of the name, nick name, image, likeness, initials, mark, appearance, signature (including
reproduced signature), autograph, endorsement, voice, and biographical material (including history, video and motion picture film
portrayals, and still photography), Internet domain names and online social media user/screen names of Ms. Ireland and has developed
and used intellectual property (collectively, the “Ireland
IP’’) and is engaged in the licensing of the property identified in the attached Exhibit
A (hereinafter, with the Ireland IP, collectively referred to as the “Licensed
Marks”);

 

WHEREAS,
Licensee is a manufacturer and seller of Cosmeceuticals and other age defying products with biologically active or biologically
derived ingredients and desires to use the Licensed Marks, as specifically defined in Paragraph 1.1 below, in connection with the
manufacture, sale, and distribution of the Licensed Products, as specifically defined in Paragraph 1.6 below, subject to the terms
and conditions provided herein; and

 

WHEREAS,
in addition to agreeing to Licensee’s use of the Licensed Marks, Licensor wishes to cooperate with Licensee in order to develop,
promote, and expand recognition of the Licensed Marks image for the mutual benefit of Licensor, Licensee, and Licensee’s
customers;

 

WHEREAS,
Licensee agrees to fully comply with kiWW Human Rights –  Code of Conduct, EXHIBIT
C and,

 

NOW,
THEREFORE, in consideration of the mutual promises herein contained, it is hereby agreed:

 

1.     DEFINITIONS

 

		1.1	The term “Brand”
shall mean the Licensed Products offered under the Licensed Marks.

 

		1.2	The
                                         term “Allowance” or “Allowances” shall mean any
                                         reductions in the wholesale sales price of any Licensed Product by promotional off-invoice
                                         amounts or accruals which are directly reflected in Licensee’s written vendor agreement(s)
                                         with the specific retailer customer to which the Allowance applies.

 

    	-1-

    	 

    

 

		1.3	The term “kathy ireland Worldwide Corporate Headquarters”
shall mean Rancho Mirage, California, 92270.

 

		1.4	The term “Channels
of Distribution” shall mean only those channels, which are listed on Exhibit B attached hereto and incorporated
by reference herein. Exhibit B may only be modified, supplemented, and/or amended by written agreement of the Parties as provided
herein.

 

		1.5	The term “Licensed
Marks” shall mean only those of Kathy Ireland’s name, likeness, visual representation and/or each of the
individual components thereof, and those trademarks, service marks, logos, designs, and/or any other symbols/devices, which are
set forth in Exhibit A attached hereto and incorporated by reference herein.

 

		1.6	The term “Licensed
Products” shall mean only those items, which are listed in Exhibit B attached hereto. Exhibit B may be modified,
supplemented, and/or amended solely by written agreement of the Parties as provided herein.

 

		1.7	The
                                         term “Manufacturing Territory” shall mean all countries worldwide
                                         other than Russia.

 

		1.8	The term ‘Territory”
shall mean the United States of America,, Canada and all other countries worldwide, other than Russia which is specifically
excluded.

 

		1.9	The
                                         term “Net Sales” shall mean the gross invoice amount billed (exclusive
                                         of any and all sales, Value Added Tax (“VAT”), Handling charges and
                                         restocking fees, excise, local privilege or any other taxes collected from customers
                                         and owed or actually paid by Licensee to any government entity and exclusive of any and
                                         all shipping and handling charges, in all cases) to customers purchasing or receiving
                                         Licensed Products from Licensee, less Allowances, and less Trade Discounts for Licensed
                                         Products given to wholesale customers actually shown on the invoices and actually given
                                         to the customers (except cash discounts, which are not deductible in the calculation
                                         of Royalty) and, further, less any bona fide Returns, not to exceed 2.5% of gross receipts
                                         per annum and actually made or allowed, or credits actually issued in lieu of Returns
                                         of the Licensed Products, as supported by credit memoranda actually issued to wholesale
                                         customers (subject to the pricing provisions of Section 5.1). No other costs incurred
                                         in the manufacturing, selling, advertising, and/or distribution of the Licensed Products
                                         shall be deducted

 

		1.10	The term “Parties”
and/or “Party” shall
mean Licensor and/or Licensee.

 

		1.11	The term “Returns”
shall mean any Licensed Product, which Licensee accepts back from any customer after purchase and delivery thereof and for which
Licensee refunds the actual purchase price, or issues a credit memo.

 

		1.12	The term “Termination
Date” shall mean the date, whichever is earliest, that (i) this Agreement (subject to any renewals or extensions)
expires by its own terms; (ii) is thirty (30) days after receipt of notice of termination under Section 22; or (iii) any other
event occurs which terminates this Agreement where no notice is required.

 

		1.13	The
                                         term “Trade Discounts” shall mean any reductions or charge backs in
                                         the wholesale sales price of any Licensed Product, and actually granted by Licensee in
                                         writing to any customer prior to delivery.

 

    	-2-

    	 

    

 

		1.14	The term “Initial
Term” shall mean Contract Year 1 through Contract Year 8 plus any extensions, renewals of this Agreement or written
modifications thereof.

 

		1.15	The term “Contract
Year 1” shall mean the period of time from the Effective Date, defined to mean the date on which both Parties
have executed this Agreement, through and including December 31, 2015.

 

		1.16	The term “Contract
Year 2” shall mean the period of time from January 1, 2016 through and including December 31, 2016.

 

		1.17	The term “Contract
Year 3” shall mean the period of time from January 1, 2017 through and including December 31, 2017.

 

		1.18	The term “Contract
Year 4” shall mean that period of time from January 1, 2018 through and including December 31, 2018 and Contract
Years 5 through 8 shall mean the calendar years ending through December 31, 2019, 2020, 2021 and 2022, respectively.

 

		1.19	The term “Royalty”
                                                                                                                    or “Royalties”
                                                                                                                    shall have that meaning set out in Paragraph 5.1 below.

 

		1.20	The term “Term”
shall mean the Initial Term plus any extensions, renewals of this Agreement or modifications thereof.

 

		1.21	The term “Minimum
                                         Royalty Guarantee” shall have the meaning set forth in Paragraph 5.8
                                         below.

 

		1.22	The term “Minimum
Net Sales” shall have that meaning set forth in Paragraph 3.7 below.

 

		1.23	The term “Business
Plan” shall mean a merchandise strategy and business plan for the Brand, including any supporting brands set
forth in Exhibit A.

 

2.     GRANT
OF LICENSE

 

		2.1	Upon the terms and conditions set forth herein, Licensor
hereby grants to Licensee the exclusive, non-transferable right, license, and privilege, and Licensee hereby accepts the exclusive,
non-transferable right, license, and privilege, of using the Licensed Marks for the sale, marketing and distribution of the Licensed
Products through the Channels of Distribution in the Territory during the Term (with the exceptions as stated on Exhibit B), and
the non-exclusive, non-transferable right, license, and privilege of using the Licensed Marks in connection with the manufacture
of Licensed Products in the Manufacturing Territory.

 

		2.2	Licensee agrees that it will not distribute or sell, nor
authorize anyone else to distribute or sell, the Licensed Products bearing the Licensed Marks outside of the Territory or the
Channels of Distribution, and that it will not knowingly sell Licensed Products bearing the Licensed Marks to persons who intend
to distribute or sell the Licensed Products outside of the Territory or the Channels of Distribution.

 

    	-3-

    	 

    

 

		2.3	During the Term, Licensor agrees that it will not authorize
others to distribute or sell the Licensed Products bearing the Licensed Marks in the Channels of Distribution in the Territory.
Licensee acknowledges that Licensor may continue to license the Licensed Marks and related marks to others to develop and promote
other lines apart from and not competitive with the Licensed Products in the Channels of Distribution in the Territory during
the Term. Notwithstanding the foregoing the parties acknowledge that Licensee may be able to utilize established, reputable and
regional distributors in foreign countries to promote the marketing, sale and distribution of Licensed Products and enhancement
of the Brand.

 

		2.4	All proposed Channels of Distribution and distribution
outlets not approved in Exhibit B shall be submitted in advance to Licensor and shall be subject to Licensor’s prior written
approval, which approval shall not be unreasonably withheld.

 

		2.5	Licensee may not assign or sub-license the use of the Licensed
Marks to any third party without prior written approval by Licensor, and such right is expressly withheld from this Agreement.
In the event that Licensor approves a sub-license to a third party, the Parties shall mutually agree upon the terms and conditions
of said sub-license, including without limitation the minimum royalty guarantee and royalty rate, in a separate writing signed
by the Parties.

 

		2.6	Licensee currently
                                         uses sub-contractors or other fulfillment houses to manufacture, make compounds and/or
                                         package its current products and intends to continue using such subcontractors and fulfillment
                                         houses for Licensed Products, however, such products shall only be for sale to Licensee
                                         or Licensee’s customers as sub-contractor of Licensee. By executing this Agreement
                                         Licensor shall be deemed to have approved all current sub-contractors of Licensee, provided
                                         however, that any selection of new sub-contractors must be approved by Licensor in writing
                                         (including being audited for compliance with local laws and the Approved Code of Conduct,
                                         if reasonably required by Licensor to do so, such audit results being satisfactory to
                                         Licensor in its sole discretion), must agree to be bound by the same terms and conditions
                                         as is Licensee under this Agreement, and Licensee must execute a Sub-Contractor Agreement,
                                         and provide to Licensor. Licensee will ensure that any sub-contractors will comply with
                                         all local laws regarding compensation, workplace conditions and worker ages. Licensee
                                         shall use its reasonable commercial efforts to allow Licensor or any third party auditors
                                         designated by Licensor to have reasonable access to sub-contractors’ production
                                         facilities. Further, Licensee will, and will endeavor to have its sub-contractors to,
                                         in good faith comply in all material respects to the standards of Licensor’s code
                                         of conduct or any other specific reasonable code of conduct adopted by Licensor from
                                         time to time that are also consistent with local law and practice. Licensor may withdraw
                                         its consent and approval of any sub-contractor at any time at the sole discretion of
                                         Licensor, for good cause reasonably applied and upon reasonable notice so as to allow
                                         Licensee reasonable opportunities to secure alternates under conditions that will not
                                         disrupt operations of Licensee. Licensor’s approved code of conduct is attached
                                         as Exhibit C and incorporated by reference herein (the “Approved Code”).
                                         If Licensee or any of its sub-contractors are not in material compliance with local laws
                                         or the Approved Code, Licensor, in its sole discretion, may terminate this Agreement
                                         after written notice and an opportunity to cure any such lack of compliance of not less
                                         than thirty days. Notwithstanding the foregoing, nothing herein set forth shall apply
                                         to general suppliers of commodities or vendors of ingredients and other goods that are
                                         generally “off the shelf”. A list of Licensee’s principal suppliers shall
                                         be attached to this Agreement within two business days from the date on which all Parties
                                         have executed it as Exhibit H and as of the Commencement Date are deemed approved.

 

    	-4-

    	 

    

 

		2.7	The name and address of any manufacturer or sub-contractor,
other than Licensee, chosen to manufacture the Licensed Products as permitted under this Agreement and all items related thereto,
including without limitation labels, hang tags, and packaging, shall be disclosed to Licensor and approved by Licensor in writing
prior to production of the Licensed Products and items related thereto, which approval shall not be unreasonably withheld and
provided that such approvals or disapprovals shall be delivered to Licensee within five (5) business days following receipt by
Licensor of any such written request that should be sent to the attention of Stephen Roseberry, and or such other person or persons
as may be designated from time to time by Licensor, and if not so delivered shall be deemed approved. The Parties further agree
to have meaningful consultation prior to the selection and use of any new sub-contractors, vendors, and/or manufacturers. Licensor’s
approval of sub-contractors proposed by Licensee shall be in the sole discretion of the Licensor reasonably applied. Notwithstanding
the foregoing, these conditions do not apply to product formulations. Newly developed products by Licensee shall be mutually agreed
upon in advance of adding that product to the line of Licensed Products. Licensor shall not unreasonably withhold such approval
and if disapproved by Licensor, Licensee may market such new product provided that none of the Licensed Marks appear on that new
product.

 

		2.8	During the life of this Agreement, Licensee will not sell
or distribute products that directly compete with the Licensed Products unless mutually agreed upon in writing by both Parties,
and provided that Licensor shall be allowed a right of first refusal to include within Licensed Products any new or other products
developed by Licensee over or during the Term.

 

		2.9	Licensee will not be permitted to enter into any other
branded relationship that competes with Licensor’s Branded program under this Agreement without the written approval of
Licensor. If Licensor grants such approval, the product assortment for such other relationship will not exceed the volume of Licensor’s
Branded program. By way of example, however in no way comprehensive, competitive brands are Trina Turk, Martha Stewart, Jessica
Simpson and similar fashion and lifestyle type brands. In addition, Licensee will not create any branded products itself (i.e.,
in-house) that competes with the Licensor’s branded program. Licensor acknowledges that Licensee currently also markets
certain other goods and products through a separate division or subsidiary of a pharmaceutical grade used or intended primarily
for treatment of disease or a disease condition and which may require approval from the United States Food and Drug Administration
and any of such products, not bearing Licensed Marks may be sold through physicians and over the counter and are excluded from
these or any other limitations that may be herein set forth.

 

3.     BRAND
DEVELOPMENT

 

		3.1	Licensee will utilize commercially reasonable efforts to
conduct market research and design support and to develop a merchandise strategy and business plan for the Brand. Licensee shall
submit the Business Plan to Licensor for its review and approval within ninety (90) days of the Effective Date of this Agreement.
The Parties shall work in good faith to craft a Business Plan that shall best promote and benefit the Brand.

 

		3.2	Licensee will develop a long term strategic plan for major launch(es) of the Brand in the
                                                                              Channels of Distribution and Territory which shall be subject to the approval of the Licensor, such approval not to be
                                                                              unreasonably withheld (the “Launch Plan”). If Licensee has not launched any Licensed Product into any
                                                                              Channels of Distribution under the Brand by April 15, 2015, Licensor may give written notice of its intent to terminate this
                                                                              Agreement (the “Cure Notice”), following receipt of which Licensee shall be allowed an opportunity to cure this
                                                                              failure, and Licensee’s failure to launch within thirty (30) days following delivery of the Cure Notice shall cause a
                                                                              termination of this Agreement. The international segment of the Launch Plan will identify a new region or country within the
                                                                              Territory(ies) for distribution Licensed Products six (6) months (identification period) from the initial domestic launch
                                                                              date of April 15, 2015. Licensee will have eighteen (18) months to effect each launch into a new region or country within the
                                                                              Territory from the end of the identification period for each region or county within the Territory. Following each such 18
                                                                              month roll out period, Licensee shall be permitted a further six months to identify new region or country within the
                                                                              Territory, and upon such identification, Licensee shall be permitted 18 months to effect this new launch. Licensee shall
                                                                              continue this rollout for each new region or country within the Territory during the Term of this Agreement..

 

    	-5-

    	 

    

 

		3.3	Licensee will begin shipping of Licensed Products prior
to April 15, 2015.

 

		3.4	Licensee will utilize commercially reasonable efforts to
cooperate with Licensor to develop cross merchandising strategies with other licensees of Licensor to capitalize on the success
of the Licensed Marks and the Ireland IP.

 

		3.5	Licensee will utilize commercially reasonable efforts to
develop a strategic four year sales growth plan to reach or exceed the forecasted minimum net sales goals set forth in paragraph
3.7 below

 

		3.6	Licensee agrees that all designs, images, sketches and
names of Licensor and those which may be created by Licensor as a result of this Agreement for use on Licensed Marks proprietary
to Licensor, and to the extent Licensee has any rights in such materials including all intellectual property in connection therewith,
Licensee agrees to assign and does hereby assign to Licensor (or any person or entity designated by Licensor) all of its right,
title and interest in and to such intellectual property. Except as so indicated nothing herein set forth shall be deemed to transfer
or to grant any property interest in any trade designs, sketches, images, products, compounds, manufacturing processes, or other
interests of Licensee independent of the Licensed Marks and Ireland IP to any of the products that Licensee markets or that it
may in the future market, Licensor’s rights being limited to its Licensed Marks hereunder, and the Ireland IP.

 

		3.7	Licensee will make commercially reasonable efforts to meet
the following minimum totals of Net Sales of Licensed Products for the specified periods:

 

	Period	 	Forecasted Minimum Net Sales	 
	Contract Year 1	 	$	1,500,000.00	 
	 	 	 	 	 
	Contract Year 2	 	$	2,500,000.00	 
	 	 	 	 	 
	Contract Year 3	 	$	3,750,000.00	 
	 	 	 	 	 
	Contract Year 4	 	$	5,000,000.00	 

 

		3.8	Notwithstanding anything herein to the contrary, should
Licensee fail to meet the Minimum Net Sales in any given Contract Year, Licensee, shall nevertheless pay the minimum royalty required
for that Contract Year.

 

		3.9	Licensee will endeavor promptly to provide to Licensor
any material trend or forecast or other industry information it obtains of a nature that may be requested by Licensor from time
to time.

 

    	-6-

    	 

    

 

		3.10	Licensee upon written request from Licensor agrees to become
a member of Send Out Cards within 30 days of receipt thereof. Licensee will use Send Out Cards, or a comparable service, as a marketing
tool to help communicate our Partnership and promote sales.

 

		3.11	Licensee agrees to become a member and utilize salesforce.com
or any similar web platform as may be utilized by Licensor from time to time as a means of conducting Brand business and coordinating
with Licensor and other licensees.

 

		3.12	Licensed Products bearing the “kathy ireland”
mark may not be sold in the home improvement, drugstore, or food and grocery Channels of Distribution.

 

4     TERMS

 

		4.1	The term of the license hereby granted shall commence effective
the date on which both Parties have executed this Agreement (the “Effective Date”) and shall be effective through
the end of the Initial Term, unless terminated sooner in accordance with the provisions hereof.

 

		4.2	Licensee shall have an option to renew this Agreement for
an additional term of up to four years and it shall be renewed, commencing on the first business day after the end of the Initial
Term, only so long as the following conditions are met:

		i)	This Agreement has not been terminated for any reason prior
to the expiration of the Initial Term;

 

		ii)	At least six (6) months prior the expiration of the Initial
Term, Licensee tenders a written notice to Licensor of its intent to exercise the option to renew the Agreement (the “Extension
Notice”);

 

		iii)	Licensee is in material compliance with this Agreement,
including but not limited to all Minimum Guaranteed Royalty requirements at the date of the Extension Notice and continuing through
the expiration of the Initial Term; and,

 

		iv)	By September 30, 2018, the Parties have agreed to Minimum
Guaranteed Royalty for the renewal term.

 

		4.3	The period during which the Agreement is in full force
and effect including both the Initial Term and any extension thereof shall be the Term.

 

5     ROYALTY
AND PAYMENT

 

		5.1	In consideration of the grant hereunder, Licensee shall
pay Licensor royalties in U.S. dollars at a rate of five percent (5%) of the Net Sales for all Licensed Products sold and collected
under the Licensed Marks. Licensee further agrees to utilize commercially reasonable efforts to increase sales of the Licensed
Products during each year of the Term. If any sales of Licensed Products are made in currencies aside from the U.S. dollar, then
Royalty payments for those sales shall still be made in U.S. Dollars and shall be based on the equivalent amount in local currency
calculated on the basis of the exchange rate or rates actually paid by Licensee less reasonable and customary bank fees and related
exchange charges actually incurred by Licensee with respect to non-U.S currencies, as certified by Licensee’s independent
auditing firm or other third party reasonably acceptable to Licensor.

 

    	-7-

    	 

    

 

		5.2	In addition Licensor shall endeavor to utilize reasonable commercial efforts to introduce
                                                                              Licensee to established retail channels of distribution. If such introductions lead to additional sales, then in addition to
                                                                              the royalty payable under 5.1, Licensee shall pay Licensor an additional royalty of one percent (1%) of Net Sales received
                                                                              by, or derived from any new retail customer that Licensor brings to Licensee that is not a current or former customer of
                                                                              Licensee.

 

		5.3	Licensee’s Royalty obligation shall accrue upon and
be paid wholly from the receipt of revenue from all sales or distributions of Licensed Products. Licensee’s Royalty obligation
for sales shall accrue upon the sale of each Licensed Product, payable following the time of collection by Licensee and pursuant
to Section 1.9 above. Such an item shall be considered “sold” when it is billed, invoiced, delivered, transferred
to a customer or shipped, whichever occurs first. If Licensee distributes or sells any Licensed Product to any affiliated or related
party, other than any sale or distribution to Licensor, at an amount that is less than Licensee’s lowest wholesale price
charged in arms-length sales to other parties, the Royalty shall be computed at Licensee’s lowest wholesale price charged
in like arms-length sales to non-affiliated third parties.

 

		5.4	If the payment of funds to Licensor in any country is blocked
from export out of any country in the Manufacturing Territory (“Blocked Funds”), such payment either may be
held by Licensee, or, at the election of Licensor, deposited in an interest-bearing escrow banking or other interest-bearing escrow
account, in Licensee’s name on behalf of Licensor in the blocking country (if permitted by local law) or may be removed
from such country and paid to Licensor, subject to whatever restrictions, limitations, and/or taxes may be imposed by the government
of such county upon such Blocked Funds. In the event of any such blockage, Licensor and Licensee shall cooperate in seeking an
equitable solution. If no such solution is attained in 90 days Licensor may require Licensee to, or Licensee may voluntarily upon
notice to Licensor, terminate Licensee’s marketing and sale of Licensed Products in such blocked country, and this Agreement
shall be deemed amended accordingly.

 

		5.5	Within fifteen (15) business days after the end of each
month, Licensee shall furnish to Licensor a complete sales and royalty report certified to be accurate by the Chief Financial
Officer of Licensee or by some other authorized designee of Licensee showing the number, description, and Net Sales Price of the
Licensed Products distributed and/or sold by Licensee during the preceding month, as well as the number of Licensed Products in
inventory at the beginning and end of the month. For this purpose, Licensee shall use the approved report form attached hereto
as Exhibit E and incorporated by reference herein. Such report shall be furnished to Licensor whether or not any of the Licensed
Products have been sold during the preceding month. Licensee shall tender both hard copy sales and royalty report and sales in
royalty report in Excel spreadsheet format to Licensor. A Sales and Royalty report including amounts collected will be furnished
separately for each brand listed in Exhibit A in Excel spreadsheet format to the Licensor and sent to:

 

Erik Sterling and Financial Committee

P.O. Box 1410

Rancho Mirage, CA 92270

Via Email: esterling@sterlingwinters.com and

FinancialCommittee@sterlingwinters.com

 

    	-8-

    	 

    

 

		5.6	The receipt or acceptance by Licensor of any of the reports
furnished by Licensee pursuant to this Agreement or of any royalties paid by Licensee hereunder (or the cashing of any royalty
checks paid by Licensee hereunder) shall not preclude Licensor from questioning the accuracy thereof at any time, and in the event
that any inconsistencies or mistakes are discovered in such reports or payments, any inconsistency, mistake, or inaccuracy shall
immediately be rectified, and any appropriate payment due and owing shall immediately be paid by Licensee to Licensor.

 

		5.7	At the time Licensee delivers the above-referenced royalty
reports to Licensor, Licensee shall pay all royalties due and owing directly to Licensor as indicated in the sales and royalty
report for the month in which earned and collected. Unless otherwise instructed by Licensor, all payments required by this agreement,
shall be sent via wire transfer to the account indicated below, or to any other account designated in writing by Licensor. Licensee
will send separate wires and reports for each Brand.

 

If to: Licensor:

kathy ireland Worldwide, Inc.

2000 Avenue of the Stars, Suite 210

Los Angeles, CA 90067

Comerica Bank

Domestic Wire - Routing #121137522

Account Name: kathy ireland Worldwide

Account #: 1891-935809

 

		5.8	Licensee shall pay Licensor the following Minimum Guaranteed
Royalties on the schedule set out below:

 

	Time Period	 	Minimum Guaranteed
 Royalty Payment	 	 	Payment Due Bate
	Contract Year 1	 	$	100,000.00	 	 	45 days after quarter end
	Contract Year 2	 	$	150,000.00	 	 	45 days after quarter end
	Contract Year 3	 	$	200,000.00	 	 	45 days after quarter end
	Contract Year 4	 	$	250,000.00	 	 	45 days after quarter end

 

Notwithstanding the foregoing,
the Royalty on that portion of Net Sales which exceeds (i) $2,000,000 but is no greater than $5,000,000 in Contract Year 1, (ii)
$3,000,000 but is no greater than $10,000,000 in Contract Year 2, (iii) $4,000,000 but is no greater than $15,000,000 in Contract
Year 3 and (iv) $5,000,000 but is no greater than $20,000,000 in Contract Year 4, shall be 4% of any such excess annual sales amounts.
In addition, the Royalty on that portion of Net Sales which exceeds (i) $5,000,000 in Contract Year 1, (ii) $10,000,000 in Contract
Year 2, (iii) $15,000,000 in Contract Year 3 and (iv) $20,000,000 in Contract Year 4, shall be 4.25% on any such excess annual
sales amounts.

 

    	-9-

    	 

    

 

		5.9	Minimum Guaranteed Royalty payments shall only be credited
towards Royalties in the Contract Year for which they apply (i.e., Licensee receives credit towards Royalties for the Minimum
Guaranteed Royalty payment made in that particular Contract Year). Credits for Minimum Guaranteed Royalty payments do not carry
over into prior or subsequent Contract Years. The Parties understand and agree that each payment, whether it is a Royalty or the
Minimum Guaranteed Royalty amounts as set forth above, is a separate and independent obligation. The minimum royalty for Contract
Years 5 through 8 will adhere to the same minimum guarantee royalty payment escalation schedules as in previous years.

 

		5.10	Any amount (i.e., Royalties, Minimum Guaranteed Royalties,
Brand Participation Fees, and other payments due hereunder) not paid to Licensor within fifteen days of when due under this Agreement
shall bear a late payment charge on the unpaid balance at the rate of 1.5% per month, or the maximum amount permitted by law,
whichever is less.

 

		5.11	In addition to the payments above, Licensee shall pay Licensor
the following brand participation fees (the “Brand Participation Fee”) on the following calendar year dates for the
purpose of general advertising, good will and promotion of the overall kathy ireland brand (not limited solely to the Licensed
Products produced by Licensee under this Agreement, but the for benefit of the entire kathy ireland brand line of products):

 

Year 1: $350,000.00 due on the Effective Date (of which $150,000,
the prior deposited receipt of which is hereby acknowledged, leaving a balance of $200,000 payable) including fees due for photo
sessions as required under paragraph 14.1 below.

 

Year 2: $50,000 due on first anniversary of contract Effective
Date.

 

Year 3: $50,000 due on the second anniversary of contract Effective
Date.

 

Year 4: $50,000 due on the third anniversary of contract Effective
Date. One percent (1%) of the total gross sales of Licensed Products in Year 3.

 

These payments will continue in Contract Years 5 through 8 in
the same manner as determined above.

 

6     ACCOUNTING

 

		6.1	Licensee shall keep accurate books of account and records
covering all transactions relating to the license hereby granted, and Licensor and its duly authorized representatives shall have
the right after giving reasonable notice at all reasonable business hours of a general day of business to an examination of said
books of account and records relating to Licensee’s performance under the Agreement, and of all other documents and materials
in the possession or under the control of Licensee including its affiliated, associated, or subsidiary companies or agents, which
reasonably and directly relate to the subject matter and terms of this Agreement, and shall have free and full access thereto
for said purposes and for the purpose of making extracts therefrom. Upon request of Licensor, Licensee shall furnish to Licensor
a detailed statement by an independent certified public accountant showing the number, description, and Net Sales of the Licensed
Products covered by this Agreement distributed and/or sold by Licensee to the date of Licensor’s demand. All books of account
and records shall be kept available for no less than seven (7) years.

 

    	-10-

    	 

    

 

		6.2	Within seventy five days after the close of each calendar
year or, if applicable, five business days after the parent of Licensee may deliver its report on its annual sales as filed with
the United States Securities and Exchange Commission, whichever is later, during the Term or any renewal thereof, Licensee shall
furnish to Licensor an updated audited financial statement for the preceding calendar year or such other financial information
as may be reasonably requested by Licensor.

 

		6.3	Each calendar year in which this contract is in effect,
and once after expiration or termination of this Agreement, Licensor shall be entitled to an independent audit of and be given
access to Licensee’s account books, records, invoices and other pertinent data relating to Licensee’s performance
under this Agreement during the prior contract year (“Licensor’s Performance Audit”) by a certified public accountant
or qualified auditor designated by Licensor. Licensor’s Performance Audit shall be conducted to determine, inter alia, Licensee’s
accounting reports and sales of Licensed Products, as well as all Returns and Trade Discounts, and shall be conducted during normal
business hours at Licensee’s business office or location of such files and records. The cost of Licensor’s Performance
Audit shall be borne by Licensor unless the audit reveals that Licensee understated sales and or royalties of Licensed Products
by more than five percent (5%), in which case Licensee may be required to pay the actual reasonable costs of such audit together
with any outstanding balance revealed to be payable by such audit. Notwithstanding the foregoing, should Licensee, or if applicable
its parent be engaged in or otherwise in the midst of completing audited financial statements and other year-end documents needed
to be filed with a federal or state regulatory agency, Licensor shall cooperate with Licensee in deferring commencement of Licensor’s
Performance Audit. In the event that there arises a discrepancy between Licensor’s Performance Audit and the financial statements
reported on by the independent registered accounting firm retained by Licensee or its parent the matter shall be submitted to
arbitration in accord with the provision of Section 36 below.

 

		6.4	Licensor’s exercise in whole or in part inspect records
or accounts, Licensor’s acceptance of any statement or statements from, or the receipt our acceptance by Licensor of any
payment tendered by or on behalf of, Licensee, shall be without prejudice to Licensor’s rights or remedies permitted by
this Agreement or as a matter of equity of law, and shall not preclude or prevent Licensor thereafter disputing the accuracy of
any such statement or payment.

 

7     QUALITY
ASSURANCE

 

		7.1	Licensee acknowledges the good reputation of Ms. Ireland,
and further acknowledges that all Licensed Products manufactured, distributed, and/or sold by Licensee will enhance the reputation
and recognition of Ms. Ireland to the mutual benefit of the Parties. The quality of the Licensed Products shall be consistent
with or exceed the average of similar products manufactured, distributed, and/or sold by Licensee, shall serve to enhance Brand
recognition of the Licensed Products to the mutual benefit of the Parties, and shall be generally suitable for the use for which
they are intended.

 

    	-11-

    	 

    

 

		7.2	All Licensed Products developed, manufactured and sold
hereunder, and all labels, hang tags, packaging, catalogs, brochures, publications, printed matter, advertising, signs, promotional
displays, websites, web pages, video and sound recordings, online social media pages (hereinafter the ‘‘Promotional
Materials”) and other forms of publicity material for the Licensed Products, shall be subject to Licensor’s written
approval in advance of use, distribution, marketing or sale. Without cost to Licensor, Licensee shall submit to Licensor for its
inspection and approval, at least three (3) samples of each Licensed Product, sign, promotional display, label, hang tag, packaging,
catalog, brochure, publication, printed matter, advertising, video and sound recording, and other forms of publicity material
including but not limited to website and online social network pages for the Licensed Products depicting the Licensed Marks (hereinafter
the “Samples”), prior to any use, marketing, advertising, sale or other distribution to the public. In lieu of submitting
three (3) samples of the Promotional Materials under this Paragraph 7.2, Licensee may submit either a computer diskette or e-mail
attachment containing a depiction of one (1) sample for Licensor’s inspection and approval. Licensor’s representative,
or any duly authorized representative of Licensor designated by it in writing, shall have ten (10) days from Licensee’s
delivery to Licensor of the Samples to approve or reject in writing such Samples. If any such time period lapses without Licensee
receiving express written approval or rejection of the supplied samples, the samples will be deemed approved by Licensor, provided
that copies of all correspondence accompanying the samples are submitted or sent to Licensor’s counsel in accordance with
the notice provisions of Section 24. Licensee shall not manufacture, distribute, market and/or sell any Licensed Product, or Promotional
Material depicting or incorporating the Licensed Marks until Licensee has received Licensor’s written approval of the Sample,
provided that Licensor shall respond promptly and that such approval shall not be unreasonably withheld. In the event of a disapproval
the Parties shall collaborate in making requested constructive changes that are being reasonably requested. Once Licensor approves
a Sample under the terms herein, that Sample will be deemed approved for all uses unless it is materially modified. From time
to time after Licensee has commenced selling the Licensed Products, and upon Licensor’s request, Licensee shall furnish
without cost to Licensor a minimum of two (2) additional random samples of each Licensed Product being manufactured and sold by
Licensee hereunder (and, if requested, detailed photographs, descriptions, and/or videos of the Licensed Product(s), together
with the related materials, if any, used in connection therewith.

 

		7.3	All materials submitted for approval to Licensor in a language
other than English will be accompanied by a complete and accurate English translation.

 

		7.4	In addition to the standards required above, Licensee acknowledges
the great value of the goodwill associated with Ms. Ireland and the Licensed Marks and the worldwide recognition thereof, and
Licensee agrees that it will not use the Licensed Marks in any manner which, directly or indirectly, would demean, ridicule or
otherwise tarnish the reputation or image of Licensor, Ms. Ireland or the Licensed Marks. Without limiting the foregoing, (i)
all Licensed Products shall in all respects be manufactured, marketed and distributed in a manner consistent with the high quality
standards and image of Licensor, and (ii) Licensee shall not permit the manufacture, marketing or distribution of any Licensed
Product that represents, depicts or promotes (a) the glorification of violence, including but not limited to any representations
of gang- or terrorist-related imagery, firearms or explosive devices, (b) sexual activities, including but not limited to any
representations of body parts or sex toys, (c) religious beliefs, including but not limited to any religious iconography or any
image commonly associated with any religious organization or cult, (d) any political content or (e) tobacco, alcohol or drug use.

 

		7.5	Should any Licensed Product fail to meet the quality standards
established by this Section, or fail to be manufactured, sold, and/or distributed in accordance with the same or higher quality
standards and all applicable federal, state, and local laws, or industry standards, or be subject to recall by any government
or industry organization, except as provided herein, the offending products may be removed from distribution and sale as Licensed
Products following notice as set forth below in this paragraph, and Licensor thereafter shall have the right to remove that product
from the list of Licensed Products. If any such condition or circumstance shall occur then within thirty (30) days following receipt
of written notice thereof, then if such conditions or circumstances are not substantially corrected, Licensor shall have the option
to remove the offending product from the list of Licensed Products under this Agreement in its sole discretion.

 

    	-12-

    	 

    

 

		7.6	Licensee, from time to time, shall have the right to sell
goods deemed irregulars and second quality as instructed by Licensor under the same royalty conditions as set out in Section 5.1
above. Licensee may sell such seconds in a way which shall not reduce the value of the Licensed Mark(s) or detract from Licensors
or Ms. Ireland’s reputation and shall obtain the written approval of Licensor with respect to the terms and method of such
disposal. The percentage of “seconds” of any Licensed Products which may be disposed of in any given year pursuant
to this section shall not, in any event, exceed five (5%) percent of the total number of units of that particular licensed product
distributed or sold by Licensee in that year.

 

		7.7	If any retail customer of Licensee notifies Licensee or
claims to Licensee that there is a significant quality issue with any Licensed Products sold to it by Licensee, Licensee shall
notify Licensor in writing of such alleged quality issues within five business days of being notified by the retailer customer
involved.

 

		7.8	From time to time, Licensor shall notify Licensee of consumer
quality issues received by Licensor by Licensor’s “kathyireland.com” website. Licensee shall reply back to applicable
consumers within seven business days of its receipt of the issues from kathyireland.com.

 

		7.9	Licensor will have the right to purchase products from
the Licensee at cost for personal use, wear testing, giveaways, and other promotional uses, all of which uses the parties anticipate
will not exceed $100,000 per year of Licensed Products determined by reference to Licensee’s suggested retail prices. Products
purchased hereunder shall not be for commercial resale.

 

		7.10	Licensor shall have the right to inspect Licensee’s
manufacturing premises for the sole purpose of ensuring that Licensed Marks and the quality of the Licensed Products are satisfactory.
Licensee will permit a duly authorized representative of Licensor to perform such inspection during normal business hours upon
reasonable notice for the purpose of ascertaining or determining compliance with this provision. Licensor will notify Licensee
at least five (5) Days in advance of any requested inspection date. All communication, verbal and written, will be conducted through
Licensee during the Term of this License Agreement and for a period of three years thereafter. All information regarding the manufacturer
is considered to be valuable and therefore confidential between Licensee and Licensor.

 

8     DISPLAY
OF MERCHANDISE

 

		8.1	Licensee agrees to maintain space in its showroom located
in various high traffic locations and dedicated to display of the Licensed Products under the Brand. Licensee further agrees that
the Licensed Products shall be displayed at Licensee’s showroom in the most favorable manner possible to enhance the recognition
of the Brand and the Licensed Products to the mutual benefit of the Parties. The display of the Licensed Products shall be subject
to the written approval of Licensor prior to any display thereof.

 

    	-13-

    	 

    

 

		8.2	All signage related to the Licensed Products shall be maintained,
cleaned, updated, and replaced regularly so that the signage maintains a fresh appearance to enhance the Brand recognition of
the Licensed Products to the mutual benefit of the Parties. The Parties agree to have meaningful consultation as to the design
and placement of all signage. Licensor shall approve all signage in writing prior to any use thereof.

 

		8.3	Licensee may display and offer the Licensed Products on
its own company or business web page/site in a manner, which makes the Licensed Products distinctive and enhances the recognition
of the Brand and the Licensed Products to the mutual benefit of the Parties. Products other than Licensed Products bearing the
Licensed Marks may be displayed on the web page/site only with the written approval of Licensor. Licensee shall provide a link
from its web page/site to Licensor’s web page/site. In addition, Licensor’s right to approve any display of the Licensed
Products bearing the Licensed Marks on Licensee’s web page/site in writing prior to any display or use thereof, and which
shall not be unreasonably withheld and if following two business days after giving notice thereof. Licensor shall also have the
right to approve the content, look and feel of the Licensed Products on the webpage/site. Licensee shall establish its web page/site
within forty-five (45) days of the Effective Date of this Agreement and shall update its web page/site as needed on a monthly
basis.

 

		8.4	Licensee shall not supply Licensed Products to television
channels or other channels that are expressly excluded from the Channels of Distribution under this License as defined in Exhibit
B. From time to time, in its sole discretion, Licensor may seek opportunities for distribution of the Brand through certain electronic
channels of distribution not set forth on Exhibit B, and in that event, Licensee shall assist in such efforts as may be reasonably
requested by Licensor, however, Licensor is in no way bound to seek such opportunities.

 

9     LABELING

 

		9.1	Licensee agrees that it will cause to appear on or within
each Licensed Product manufactured, sold, and/or distributed under this Agreement and on or within all advertising, marketing,
promotional, or display material bearing the Licensed Marks, the appropriate trademark and copyright notices, markings, and/or
designations, and/or any other notice requested by Licensor. Each Licensed Product that is distributed and/or sold in a carton,
container, packing and/or wrapping material bearing the Licensed Marks, shall have such notices appear upon the said carton, container,
packing, and/or wrapping material.

 

		9.2	Licensee further agrees that on all descriptive and marketing
materials for the Licensed Products, a licensing statement inclusive of Licensor’s web page/site address, and a mission
statement, both subject to Licensor’s approval which shall not be unreasonably withheld, and shall appear during the term
of this Agreement and any renewal or extension thereof provided that such approvals or disapprovals shall be delivered to Licensee
within seven(7) business days following request and if not so delivered shall be deemed approved. A true and correct copy of the
licensing statement and mission statement approved by Licensor is set forth in Exhibit F attached hereto and incorporated by reference
herein. Licensor reserves the right to modify, supplement, and/or alter the licensing statement or mission statement in its sole
discretion and upon reasonable notice to Licensee. Each Related Material containing any such statements or Licensed Marks, as
well as all advertising, marketing, promotional, and/or display material which reference the Licensed Marks and/or relate to the
Licensed Products, shall be submitted to Licensor for its approval prior to any use by Licensee provided that such approvals or
disapprovals shall be delivered to Licensee within seven (7) business days following request and if not so delivered shall be
deemed approved.

 

    	-14-

    	 

    

 

		9.3	The Parties further agree that should any of the Licensed
Products be manufactured, distributed, or sold without the appropriate or requested trademark and copyright notices, markings,
and/or designations, in addition to any other rights it may have, Licensor may demand the removal of the offending product from
distribution and sale, and may remove that product from the list of Licensed Products. In that event any such product may be re-labeled
and packaged to have a different look from the prior version of the product.

 

10     PROMOTIONAL
MATERIAL

 

		10.1 	Licensee is required to provide reasonable advertising
and promotional support for the Licensed Products bearing the Licensed Marks each Contract Year including, but not limited to,
the following:

 

		a.	Licensee will budget on an annual basis not less than fifteen percent (15%) of its corporate resources
attributed to the Brand to design, market, present and sell the Licensed Products under the Brand.

 

		b.	Licensee will budget not less than seventy percent (70%) of the ratio of sales of all Licensed Products to all sales of Licensee
to the ratio its annual media-advertising budget for the Licensed Products to all products sold by Licensee.

 

		c.	Licensee will run full-page advertising in trade publications including, but not limited to, InStyle, Vanity Fair, Vogue, American
Academy of Dermatology, American Society of Plastic Surgeons to provide retail recognition for the Brand in the Physician, spa
and retail marketplaces.

 

		d.	Any print advertisements for the Licensed Products under the Brand shall be full-page advertisements. In the event that a print
advertisement of less than a full page is published, Licensee agrees to buy two (2) full page advertisements in the next issue
of the publication, and if no next issue then in a comparable publication, as well as publishing online advertising in a manner
to be agreed between the parties.

 

		e.	Licensee will use reasonable commercial efforts to convey to the market that other than products being sold under NuGene Pharma
or similar labels, it has converted all Licensed Products to the Brand, including but not limited to answering its telephones by
stating the Brand, and placing signage depicting the Brand prominently and in the first position at Licensee’s corporate
offices and showrooms and exhibition space, and on Licensee’s corporate stationery, point of sale and other marketing materials.

 

		f.	Licensee will use reasonable commercial efforts to convey to the markets in which Licensee distributes the Licensed Products
that it is a licensee of the Brand, and these efforts shall include but not be limited to placing signage depicting the Brand prominently
at Licensee’s corporate offices and showrooms, and shall also have prominence on Licensee’s corporate stationery, point
of sale, marketing and other materials.

 

		g.	Carton/box marking denoting Brand.

 

		h.	Custom Brand hangtags for each Licensed Product.

 

		i.	Point of purchase easels supplied to dealers.

 

    	-15-

    	 

    

 

 

j.
Point of purchase banners, mobiles and signage supplied to dealers as needed for display set-up.

 

k.
Licensee will use contacts in marketplace to gain product placement with key customers.

 

		1.	Licensee will merchandise the Licensed Products to motivate customers to build the Brand within stores, including opening order
discount co-op advertising and promotional discounts as needed to properly promote the Licensed Products.

 

m.
Licensee will make reasonable efforts to assure adequate public relations and press coverage of the Brand within the trade.

 

n.
Web-Based sales training programs for Brand dealers, to extent reasonably applicable or commercially productive..

 

o.Sales
event support and display set-up assistance as reasonably required.

 

p.
Custom catalog inserts, lithographs, tear sheets and brochures supporting the Licensed Products under the Brand.

 

q.
Editorial content for use on kathyireland.com.

 

		10.2	No advertising, marketing, promotional, and display materials, or other artwork shall be used without prior written approval
by Licensor, provided that such approvals or disapprovals shall be delivered to Licensee in writing within seven business days
following request and if not so delivered shall be deemed approved. The Parties further agree that all new artwork and designs
jointly created by Licensee and Licensor for the Licensed Marks shall be produced under appropriate “work for hire”
provisions, or are hereby assigned to and shall remain the property of Licensor, notwithstanding their joint creation by Licensee
and Licensor. Licensee shall ensure that, prior to its utilizing any non-employees to create advertising, marketing, promotional,
and display materials or other artwork, advertising copy, and/or other copyrightable materials related to the Licensed Marks, such
persons or entities shall have executed the necessary valid agreements to convey the ownership and copyrights to these items to
Licensor.

 

		10.3	Licensee agrees not to offer for sale, advertise, publicize, market, or otherwise promote any of the Licensed Products in any
manner whatsoever, including without limitation print media, radio, television, cable, internet, or other multi-media, without
the prior written approval of Licensor, which approval shall not be unreasonably withheld and provided further that such approvals
or disapprovals shall be delivered to Licensee in writing within seven (7) business days following request and if not so delivered
shall be deemed approved, however, notwithstanding the foregoing Licensee shall be allowed to issue press releases made in the
ordinary course of business, and in which descriptions of the License and Licensed Products are generally referenced, upon notice
delivered not later than two business days prior to the release for publication of such items consistent with the provisions of
paragraph 12.1 below.

 

		10.4	The Parties further agree that in the event Licensor elects to pay for or to otherwise make a voluntary
financial contribution to produce any advertising, marketing, promotional, and/or display materials of any kind, including without
limitation print media, radio, television, cable, internet, or other multi-media, in connection with the Licensed Products, Licensor
shall consult with Licensee but nevertheless shall have unfettered discretion to do so.

 

    	-16-

    	 

    

  

11BRAND
MANAGER

 

		11.1	Licensee agrees to establish and fill a position of Brand Manager to work with Licensor to facilitate the merchandising, promotion
and public relations, development, assortment, quality, and design of the Licensed Products. The choice of individual to fill the
position of Brand Manager shall be subject to the prior written approval of Licensor, provided that such approval or disapproval
shall be delivered to Licensee within seven business days following request, shall not be unreasonably withheld, and if not so
delivered then the choice of Brand Manager for Licensee shall be deemed approved. Said Brand Manager (or approved substitute or
replacement therefor) shall perform his/her/their duties during the term of this Agreement, and any renewal or extension thereof,
and shall cooperate with Licensor to maximize the opportunities for brand development and/or brand recognition of the Licensed
Products to the mutual benefit of the Parties. Brand Manager’s services will be in mutual cooperation with Licensor to achieve
the common goals of the Brand. Licensor acknowledges that the Brand Manager will coordinate with specific departments inside Licensee
to carry out the business under this Agreement, and that the Brand Manager will have other duties tasked to them by Licensee.

 

		11.2	Licensor may periodically hold a Brand Summit for attendance of representatives of its licensees.

 

12CONSULTATION

 

		12.1	Licensor and Licensee agree to have meaningful consultation with each other regularly throughout the term of this Agreement
and any renewal or extension thereof. The Parties agree that the purpose of the consultation will be to discuss methods and strategies
to develop, promote, and expand the kathy ireland brand and image for the mutual benefit of Licensor, Licensee and Licensee’s
customers. To attain this mutual goal of the Parties, Licensor, or its designees, agrees to meet in person from time to time as
may be reasonably appropriate throughout the calendar year, in conformity with mutually agreed upon schedules, with Licensee, or
its designees, to discuss merchandise, marketing, showroom and advertising plans and to solicit input and ideas from Licensor or
its designees. Licensor acknowledges that Licensee or a parent of Licensee may be required or may deem it appropriate to issue
press releases relating to periodic developments and Licensor agrees that it will either approve or disapprove any such press release
containing references to the Licensed Products, Licensed Marks or to Ms. Kathy Ireland, provided that (1) Licensor shall deliver
its suggestions, corrections or other comments to Licensee regarding the press release within one business day of receipt,(2) both
Licensor and Licensee shall diligently thereafter work together to assure a final version of the press release within the next
business following submission to Licensor, and (3) if Licensee has made the requested corrections or changes agreed upon or if
not otherwise disapproved in writing shall be deemed approved at the end of two business days following the initial submission
thereof by Licensee. Any disapproval from Licensor shall be accompanied by good constructive requests for changes to be made in
order for approvals to be given.

 

		12.2	Ms. Ireland is the Chief Designer of the Brand. In addition to the services provided by Brand Manager,
Licensor hereby designates Jason Winters and Jon Carrasco to serve as liaison with Licensee. Licensor may designate additional
members of the kathy ireland Worldwide team to serve as its liaison with Licensee. Licensor reserves the right to change, modify,
supplement, and/or alter this designation in any way and at any time in its sole and unfettered discretion.

 

    	-17-

    	 

    

  

		12.3	The Parties further agree that Licensor may from time to time recommend sub-contractors, vendors, and/or manufacturers to Licensee
that Licensee will consider in good faith. Licensee will use commercially reasonable efforts to use the sub-contractors, vendors,
and/or manufacturers suggested by Licensor.

 

13TRADE
SHOWS

 

		13.1	Licensor agrees to make Ms. Ireland available for two personal appearances at trade shows or other Licensee sponsored events
that promote Licensee and the Licensed Products (each a “Trade Show Event”) in the United States on behalf of Licensee
during each twelve (12) month period this Agreement is in effect. Licensee may also request that Ms Ireland make at least one appearance
in an important foreign market in connection with a public launch or distribution of Licensed Products, which Licensee as of the
date of this Agreement anticipates is likely to be in Dubai. Requests for such appearances shall be made not less than five (5)
weeks prior to the desired appearance and shall be subject to Ms. Ireland’s pre-existing personal and professional commitments
and approval. Each Trade Show Event will occur at a single location and Ms. Ireland shall not be obligated to appear for more than
(90) ninety consecutive minutes per Event (unless approved by Licensor in its sole discretion). Licensee shall not promote in any
manner any Trade Show Event as an autograph show.

 

		13.2	All travel, lodging, meals, and related incidental expenses incurred by Ms. Ireland and by all traveling companions she reasonably
requires for the personal appearances provided under this Section shall be paid by Licensee. Ms. Ireland and the traveling companions
she reasonably requires shall either travel via private plane or first class air and with portal-to-portal SUV ground transportation.
If private plane travel is used, Licensee shall pay the round trip fuel costs and landing fees for the relevant flight, and if
airline travel is used, then Licensee shall pay for first class air travel. Ms. Ireland and the traveling companions she reasonably
requires shall be lodged in first class hotel accommodations, and each shall be provided with all meals in connection with such
appearances. Where any appearance is for the benefit of multiple licensees, Licensee’s portion of expenses shall be the relative
percentage of such expenses based upon the number of other licensees involved. Licensor and Licensee acknowledge that it will be
appropriate to establish a budget in advance of any such travel that is mutually acceptable and takes into account Ms Ireland's
comfort, support and other reasonable needs and those of her travelling companions.

 

		13.3	Licensee initially to provide no later than December 5, 2014 and annually thereafter during each
November, via email to Licensor, a list of trade shows that representatives of Licensee will be attending the following year. Email
address: partners@sterlingwinters.com.

 

14
PHOTO SESSIONS

 

		14.1	Licensor shall make Ms. Ireland available to participate in at
                                         least one photo session each year during the term of this Agreement at a mutually acceptable
                                         time and place in California featuring Ms. Ireland with Licensed Products, under
                                         the Brand. These photo sessions shall be scheduled at Ms. Ireland’s convenience
                                         upon not less than five (5) weeks’ prior notice subject to her reasonable approval
                                         and pre-existing personal and professional commitments. The photo sessions may not exceed
                                         ten (10) hours in length (including hair, make-up, wardrobe, rest periods. Licensee expects
                                         within these photo sessions also to arrange for video and audio recordings that will
                                         allow Licensee promotional uses which may include: (i) short radio advertisements on
                                         Bloomberg and other radio outlets, (ii) a general website video, and marketing video
                                         and (iii) advertisements and messages suitable for promoting the Licensed Products.

  

    	-18-

    	 

    

  

		14.2	In addition to any other sums payable hereunder, Licensee shall pay to Licensor on execution of this Agreement the sum of $50,000
as payment in full for the services rendered under this section, which amount is included within the sum required to be paid under
paragraph 5.11 for Contract Year 1, and the same amount on the commencement of each Contract Year following the First Contract
Year. The Parties agree that Licensor shall have the right to produce and/or manage any such photo session in all respects. Any
amount paid under this Section shall not be included in the calculation of royalties pursuant to Section 5, or Brand Participation
Fees pursuant to Section 5.11. Licensor shall approve and deliver to Licensee fully completed photo and audio results of photo
sessions, within forty five (45) days following the date on which the photo session was conducted, suitable for immediate commercial
use by Licensee.

 

		14.3	The photographs resulting from any photo session(s) shall be contracted for under “work for hire” provisions and
all rights, including without limitation copyright, to the photos, negatives, and any other tangible materials bearing Ms. Ireland’s
image, Ireland IP or relating to said photo session(s), shall be the property of Licensor and are hereby assigned to Licensor.
If Licensee uses a photographic service of anyone other than its employees, Licensee shall obtain written assignments to the Licensor
of all copyright and other rights in any photographs, negatives, or any other materials bearing Ms. Ireland’s image. All
photographs of Ms. Ireland, which the Licensee desires to use, shall be submitted to Licensor for its absolute written approval
prior to any use thereof provided that such approvals or disapprovals shall be delivered to Licensee within seven (7) business
days following request and if not so delivered shall be deemed approved. This shall include the approval of all final retouched
versions of the photos as well as the specific negatives, which might be used.

 

		14.4	All travel, lodging, meals, and related incidental expenses incurred by Ms. Ireland or her designee and by all traveling companions
she reasonably requires for the photo session(s) provided under this Section shall be paid by Licensee, but Licensor shall endeavor
to provide no later than two business days prior thereto a reasonable estimate or budget for such costs. Ms. Ireland or her designee
and the traveling companions she reasonably requires shall travel either by private plane or via first class air and with portal-to-portal
SUV ground transportation. If private plane travel is used, Licensee shall pay the round trip fuel costs and landing fees for the
relevant flight, and if airline travel is used, then Licensee shall pay for first class air travel. Ms. Ireland or her designee
and the traveling companions she reasonably requires shall be lodged in first class hotel accommodations, and each shall be provided
with all meals in connection with such photo session(s).

 

    	-19-

    	 

    

  

15.
RECORDING & FILMING

 

		15.	Except as provided herein, under no circumstance shall
any recording be made by Licensee in any manner whatsoever, whether on video or audio tape, film, celluloid, and/or by any other
means possible, of Ms. Ireland in connection with any appearance provided under this Agreement, including without limitation all
personal appearances and photo sessions, without the prior written approval of Licensor. Should Licensor approve any such recording
of any appearance by Ms. Ireland in connection herewith, said recording shall be contracted for under “work for hire”
provisions and all rights, including the copyright, related to said recording of Ms. Ireland, shall belong solely to Licensor
and are hereby assigned to Licensor. If Licensee uses the services of anyone other than its employees to make any such recording,
Licensee shall obtain written assignments to Licensor of all copyright and other rights in any recordings, negatives, or any other
materials bearing Ms. Ireland’s image and/or voice. It is further agreed that any such recording of Ms. Ireland, which Licensee
desires to use for any purpose whatsoever, shall be submitted to Licensor for its absolute written approval prior to any use thereof.
In addition to approving the recording itself, the intended use must also be approved in writing by Licensor prior to any use
thereof. Licensee further agrees to pay Ms. Ireland’s Screen Actors Guild union costs that are attributable to her in direct
connection with her work for or with Licensee and her paid broadcasts in any media.

 

16
GOOD WILL

 

		16.1	Licensee recognizes the great value of the good will associated with the Licensed Marks and acknowledges that the Licensed
Marks are distinct and all rights therein and good will pertaining thereto belong exclusively to Licensor, and that the Licensed
Marks have a secondary meaning in the mind of the public.

 

		16.2	Licensee consistent with its general operations will take all commercially reasonable steps to
enhance the reputation of Ms. Ireland and the good will associated with the Licensed Marks, and will not intentionally do harm
thereto at any time.

 

17LICENSOR’S
RIGHTS

 

		17.1	Nothing in this Agreement shall be construed to prevent Licensor from granting any other license for the use of the Licensed
Marks or from utilizing the Licensed Marks in any manner whatsoever, except that Licensor will not maintain or grant any other
License or otherwise utilize Licensed Marks in any manner for products marketed by any non-Licensee that competes with and/or age
defying products with biologically active or biologically derived ingredients.

 

		17.2	Licensee agrees that rights not specifically granted to Licensee are reserved by Licensor and may be used by Licensor without
limitation, provided that except as specifically described, nothing herein shall impinge on or grant Licensor any rights to Licensee’s
IP.

 

		17.3	Licensee agrees to furnish any Licensed Product requested by Licensor, Ms. Ireland, or Sterling/Winters Company, at manufacturer’s
cost; provided, however, that any Licensed Product provided by Licensee under Section 7 shall be at no charge.

 

		17.4	Any approval by Licensor hereunder shall not constitute waiver of Licensor’s rights or Licensee’s duties under
any provision of the License Agreement.

 

		17.5	Licensor agrees that all patents, applications for patents, formulations, ingredients in products, trademarks, copyrights,
service marks, Internet domain names and social media user/screen names of Licensee, and the like, that have been used in the past,
and are being presently used, are all Licensee’s IP and shall remain in ownership of Licensee. Future formulations, patents, applications
for patents, scientific inventions and discoveries of new products, are also Licensee's IP and shall remain the sole property of
Licensee.

 

    	-20-

    	 

    

  

		17.6	Licensor will not hold, or grant any endorsement or similar license to any competitive brand or product line that is or will
be in competition with any of Licensed Products.

 

		17.7	Nothing herein set forth shall prohibit or prevent Licensee from obtaining any necessary, needed or otherwise appropriate
trademark, copyright, registration, trade dress, service mark, logo, or other appropriate protection of Licensee's intellectual
property or products in a timely manner including but not limited to filing actions or defending against the infringements of others.

 

18PROTECTION
OF LICENSOR’S RIGHTS;

PROTECTION
OF LICENSEE’S RIGHTS

 

		18.1	Licensee agrees that during the term of this Agreement, or thereafter, it will not register or
attempt to register any of the Licensed Marks, nor will Licensee form or incorporate any entity under a name that includes the
Licensed Marks. Licensee will not attack the title or any rights of Licensor in and to the Licensed Marks or the Licensed Products
or attack the validity of this Agreement and further acknowledges the goodwill inherent to the Licensed Marks.

 

		18.2	Licensee recognizes the great value of the goodwill that is associated with the trademarks, service marks, copyrights, Internet
domain names and social media user/screen names in the Licensed Marks, and Licensee acknowledges that, as between the Parties,
such goodwill in the Licensed Marks is owned exclusively by Licensor and any goodwill created for the Licensed Marks, by Licensee’s
use of the Licensed Marks shall inure to Licensor’s benefit. Licensee further acknowledges that, as between the Parties,
all right, title and interest in and to the trademarks, service marks, copyrights, Internet domain names and social media user/screen
names in and of the Licensed Marks are owned exclusively by Licensor. Licensee
shall not challenge or contest Licensor’s ownership of the trademarks, service marks, copyrights, Internet domain names and
social media user/screen names in the Licensed Marks, or their validity, or the validity of the license granted by this License
Agreement. Any trademarks, service marks, copyrights, Internet domain names and social media user/screen names of Licensee, including
without limitation its patents and applications for patents (collectively "Licensee's IP"), or the validity of Licensee’s
IP, shall at all times remain those of the Licensee and Licensor shall not challenge or contest Licensee's ownership of Licensee’s
IP.

 

		18.3	Licensee further agrees to cooperate fully and in good faith with Licensor for the purpose of securing and preserving Licensor’s
rights in and to the Licensed Marks. In the event there has not been a previous registration of any Licensed Mark and/or any material
relating thereto for a particular Licensed Product, Licensor may register and maintain, at its Licensee’s expense, trademarks
and/or service marks in the appropriate class(es) and/or copyrights in the name of Licensor. Licensee is not permitted to register
any copyright, trademark, and/or service mark on behalf of Licensor. It is further agreed that nothing contained in this Agreement,
and no act or omission by Licensor and/or by Licensee shall be construed as an assignment or grant to Licensee of any right, title,
or interest in or to the Licensed Marks, it being understood that all rights relating thereto are reserved by Licensor, except
for the license hereunder to Licensee of the right to use and utilize the Licensed Marks only as specifically and expressly provided
in this Agreement. It is further agreed that nothing contained in this Agreement, and no act or omission by Licensor and/or by
Licensee shall be construed as an assignment or grant to Licensor of any right, title, or interest in or to the Licensee's IP,
it being understood that all rights relating thereto are reserved by Licensee.

 

    	-21-

    	 

    

 

		18.4	Licensee also agrees to assist Licensor to the extent reasonably necessary in the procurement of any protection or to protect
any of Licensor’s rights to the Licensed Marks. Licensor, if it so desires, may commence or prosecute any claims or suits
in its own name, and Licensee may commence or prosecute any claims or suits only with the prior written approval of Licensor. Licensee
shall notify Licensor in writing within five (5) days of any infringement or imitation by others of the Licensed Marks which may
come to Licensee’s attention, and Licensor shall have the sole right to determine whether or not any action shall be taken
on account of any such infringement or imitation. Licensor may, but is not required, to seek, obtain and maintain, in its own name,
such intellectual property. Internet Domain name and social media user/screen name protection for the Licensed Marks in the Territory(ies),
which Licensor, in its sole discretion, believes to be appropriate and financially sound. Licensor in its sole discretion, shall
designate, appoint and retain, the attorney or attorneys responsible for filing, producing and maintaining all intellectual property,
Internet domain name and social media user / screen name registrations and protection for the Licensed Marks and any and all expenses
and costs associated with the foregoing shall be borne exclusively by the Licensor and not by Licensee.

 

		18.5	Licensee acknowledges that Licensor has sole and exclusive ownership of all right, title, and interest
in and to the Licensed Marks and any registrations that have been issued or may be issued thereon. Licensee agrees that it will
not at any time do or cause to be done any act or thing contesting or in any way impairing or tending to impair any part of such
right, title and interest, including without limitation applying for trademark registration in Licensee’s name for any word
or mark that is the same or likely to be confusingly similar to the Licensed Marks. Licensee further agrees that use of the Licensed
Marks shall inure to the benefit of Licensor, and that Licensee shall not at any time acquire any rights in such Licensed Marks
by virtue of any use it may make of the Licensed Marks.

 

		18.6	Nothing contained in this License Agreement shall give Licensee any right, title or interest in
or to the Licensed Marks except for the rights expressly licensed by this License Agreement, and subject to its terms and conditions.
Licensee shall not knowingly make any representation or do any act, which may reasonably be taken to indicate that it owns the
Licensed Marks, or owns any rights in the Licensed Marks other than the rights to use Licensed Marks licensed by this License Agreement.

 

		18.7	Adaptations and modifications of Licensed Marks prepared under this License Agreement shall be included as part of the Licensed
Marks.

 

		18.8	All registrations for intellectual property, Internet domain names and social media user/screen names in the Licensed Marks
are to be applied for and obtained exclusively in Licensor’s name. Licensee shall not file or register any intellectual property
applications or seek any Internet domain name and/or social media user/screen name registration in the Licensed Marks, or any derivations,
improvements, variations or modification thereof, without Licensor’s prior written approval, notwithstanding the foregoing,
nothing herein set forth shall in any way abridge the rights of the Licensee to apply for or obtain or register intellectual property
that is exclusive of the Licensed Marks or of the Ireland IP.

 

    	-22-

    	 

    

 

		18.9	Licensee shall notify Licensor, or its designated representative, prior to entering into any agreement with any
                                                             individual, company or business, for sales outside the United States of any Licensed Product, to permit the timely filing of
                                                             foreign and/or international trademark and copyright applications, or other intellectual property protection, covering the
                                                             Licensed Marks, in Licensor’s sole discretion. Licensee agrees to cooperate fully and in good faith with Licensor for
                                                             the purpose of securing and preserving Licensor’s rights in and to the Licensed Marks. In the event there has not been
                                                             a previous registration of any Licensed Mark and/or any material relating thereto for a particular Licensed Product, Licensor
                                                             may register and maintain, at its Licensee's expense, trademarks and/or service marks in the appropriate class(es) and/or
                                                             copyrights in the name of Licensor. Licensee is not permitted to register any copyright, trademark, and/or service mark on
                                                             behalf of Licensor. It is further agreed that nothing contained in this Agreement, and no act or omission by Licensor and/or
                                                             by Licensee shall be construed as an assignment or grant to Licensee of any right, title, or interest in or to the Licensed
                                                             Marks, it being understood that all rights relating thereto are reserved by Licensor, except for the license hereunder to
                                                             Licensee of the right to use and utilize the Licensed Marks only as specifically and expressly provided in this
                                                             Agreement.

 

		18.10	The Licensee shall (a) provide Licensor with copies of any material proceedings or actions affecting or involving the Licensee
including, without limitation, copies of any orders, injunctions, to which the Licensee and any of its officers or directors is
a party or subject, including those issued or sought in such proceedings or actions by a state or federal governmental agency (such
as the Department of Justice, Securities and Exchange Commission or Federal Trade Commission). At any time following the receipt
of the materials and data identified above, Licensor may request that Licensee meet with Licensor to discuss the matters covered
by such materials and data, the basis for any related claims or demands and the corrective steps that Licensee intends to take
to address and cure the related matters. If, within 90 days following the date of the meeting between
Licensor and Licensee, Licensee has not cured or discharged the matters disclosed to Licensor's reasonable satisfaction,
then Licensor may terminate the license granted under this Agreement.

 

		18.11	Licensor agrees that all patents, pending patents, formulations, ingredients in products, trademarks, copyrights, service marks,
Internet domain names and social media user/screen names of Licensee, etc., that have been used in the past, and are being presently
used, are all Licensee's IP and shall remain in ownership of Licensee. Future formulations, patents, scientific inventions and
discoveries of new products, are also Licensee's IP and shall remain the property of Licensee.

 

		18.12	Licensor will not hold, or grant any endorsement or similar license to any competitive brand or product line that is or will
be in competition with any of the Licensed Products.

 

		18.13	Nothing herein set forth shall prohibit or prevent Licensee from obtaining any necessary, needed or otherwise appropriate
trademark, copyright, registration, trade dress, service mark, logo, or other appropriate protection of Licensee’s intellectual
property or products in a timely manner including but not limited to filing actions or defending against the infringements of others.

 

    	-23-

    	 

    

  

19
WARRANTIES AND INDEMNIFICATION

 

		19.1	Licensor hereby indemnifies Licensee and undertakes to hold it
                                         harmless against any claims or suits, demands, losses, injuries, liabilities costs, judgments,
                                         arbitration awards, license fees, settlement, damages and expenses (including reasonable
                                         attorneys’ fees and costs, whether or not any legal proceeding is commenced) (“Losses”)
                                         for trademark infringement arising solely out of the validity of the rights to the Licensed
                                         Marks and from Licensee’s use of the Licensed Marks as granted herein and authorized
                                         under the terms of this Agreement, provided that prompt notice is given to Licensor within
                                         ten (10) days of any such claim or suit, and provided, further, that Licensor shall have
                                         the option to undertake and conduct the defense of any suit so brought, and no settlement
                                         of any such claim or suit is made without the prior written consent of Licensor. Licensor’s
                                         indemnification under this Section shall be apportioned and limited to only the portion
                                         of, and extent that, such Losses are, or are claimed to be, proximately caused by or
                                         attributable specifically to Licensee’s use of Licensed Marks in a manner permitted
                                         by this License Agreement. It is further agreed that Licensor reserves the right to select
                                         counsel to defend any such claims subject to the reasonable approval of the Licensee.
                                         Licensor shall be solely responsible for any and all attorneys fees, costs, and expenses
                                         of counsel relating to any and all such actions.

  

		19.2	Licensee shall defend, indemnify, and hold Licensor harmless against any and all actions, claims, demands, lawsuits, loss,
costs, damages, judgments, liabilities, license fees, settlement or expenses incurred, claimed, obtained, or sustained, including
without limitation attorneys’ fees and costs, of any nature whatsoever, whether in law or in equity, including without limitation
claims relating to or allegedly relating to the design, manufacture, sale, purchase, use, advertising, marketing, and/or distribution
of any Licensed Product, whether for personal injury, product liability, intellectual property infringement (other than Losses
arising under paragraph 19.1 above), dilution, misappropriation or otherwise. Licensor reserves the right to select counsel to
defend and/or bring any such claims, subject to the reasonable approval of the Licensee. Notwithstanding Licensor’s right
to the choice of counsel, Licensee shall solely be responsible for any and all attorneys’ fees, costs, and expenses of counsel
relating to any and all such actions.

 

		19.3	Licensor warrants that it has the lawful capacity to execute this Agreement and that it is the
owner of the Licensed Marks or the authorized licensor with right to sublicense. Licensor believes that it and Licensee are entitled
to use the Licensed Marks in commerce relating to the Licensed Products, and that to the best of its knowledge and belief, no other
person or entity has the right to use the Licensed Marks in commerce on the Licensed Products, either in the identical form or
in such near resemblance thereto as may be likely, when applied to the goods of such other person or entity, to cause confusion,
mistake, or deception.

 

		19.4	Licensor makes no representations or warranties with respect to the design, manufacture, sale, purchase, use, marketing, and/or
distribution of any Licensed Product manufactured, sold, and/or distributed by Licensee and disclaims any liability arising out
of the design, manufacture, sale, purchase, use, marketing, and/or distribution of any Licensed Product, and any such express or
implied warranties (including merchantability or fitness for a particular purpose) are hereby disclaimed.

 

		19.5	Licensee represents and warrants to Licensor that: (i) Licensee has the full power and authority
to enter into this Agreement on behalf of Licensee and to perform all of Licensee’s material obligations pursuant to this
Agreement, and that the Licensed Products manufactured, sold, and/or distributed by Licensee under this Agreement shall be suitable
for the purpose for which they are intended to be used and shall comply with all applicable laws (including federal, state, and
local), and industry standards. (ii) Licensee will not knowingly harm or misuse the Licensed Marks or bring the Licensed Marks
into disrepute, (iii) except as specifically provided in this Agreement, Licensee will not create any expenses chargeable to Licensor
or Ms. Ireland without the prior written approval of Licensor or of Ms. Ireland, (iv) all Licensed Products (and the content contained
or used in the Licensed Products) designed, developed, marketed, distributed, published, performed or sold by Licensee pursuant
to this Agreement do not, and will not, infringe any intellectual property right or any personal right of any third party, and
(v) Licensee will not knowingly permit, do or commit any act or thing that would degrade, tarnish or deprecate or disparage the
Licensed Property or Licensor’s or Ms. Ireland’s public image in society or standing in the community, or prejudice
Licensor or Ms. Ireland and that it will terminate such activities promptly following written notice, and failure to do so constitutes
a material breach of this Agreement. Licensee acknowledges and agrees that there are no warranties, guarantees, conditions, covenants,
or representations whatsoever by Licensor, express or implied, as to marketability, fitness for a particular purpose, or other
attributes of the Licensed Products, whether express or implied (in law or in fact), oral or written.

  

    	-24-

    	 

    

 

		19.6	Licensee shall provide Licensor with prompt written notice of any material lawsuits, or other significant developments, formal
investigations, or final refusals which will lead to material impact on Licensee and in which Licensee is or may be named as a
party or for which Licensee is obligated or has agreed to indemnify any party, and Licensee shall thereafter provide Licensor with
periodic written updates concerning relevant material developments in any such lawsuits as they arise.

 

		19.7	 For purposes of this Section 19, the term “Licensor” shall mean Licensor and, without limitation, any of its
agents, employees, servants, representatives, parents, subsidiaries, affiliates, officials, directors, officers, shareholders,
attorneys, divisions, branches, units, affiliated organizations, successors, predecessors, contractors, assigns, and all persons
acting by, through, under, or in concert with them, past or present, specifically including Ms. Ireland, kathy ireland Worldwide,
Sterling/Winters Company or its executives and employees.

 

    	-25-

    	 

    

 

20INSURANCE

 

		20.1	Licensee represents that it has obtained, and agrees to maintain, at its own expense, in full force and effect at all times
during which the Licensed Products are being manufactured, sold, and distributed, insurance against those risks customarily covered
under comprehensive liability policies including, without limitation, insurance for bodily injury, advertising injury, property
damage, and product liability from a recognized insurance company approved by Licensor, which approval shall not be unreasonably
withheld, and which is qualified to do business in the State of California, providing protection at least in the amount of $2,000,000
per occurrence and $2,000,000 in the aggregate in the first contract year, and at least in the amount of $5,000,000 per occurrence
and $5,000,000 in the aggregate in each subsequent contract year, against any actions, claims, demands, lawsuits, loss, costs,
attorneys’ fees, damages, judgments, and liabilities of any nature whatsoever relating to the Licensed Products. As proof
of such insurance, within 30 days of the Effective Date, Licensee shall provide certificates of insurance to Licensor, certifying
that the entities set forth under Exhibit G have been added as additional insured to each of the policies set forth above, a fully
paid certificate of insurance naming Licensor an insured party shall be submitted to Licensor for Licensor’s prior written
approval before any Licensed Product is manufactured, sold, or distributed. Any proposed change in certificates of insurance shall
be submitted to Licensor for its prior written approval. Licensor shall be entitled to a copy of the prevailing certificate of
insurance, which shall be furnished to Licensor by Licensee. The certificate(s) shall conform to the language requirements set
out in Exhibit G attached hereto. All such approvals or disapprovals shall be delivered to Licensee within five business days following
request by Licensee and if not so delivered shall be deemed approved.

 

		20.2	For purposes of this Section 20, the term “Licensor” shall mean Licensor, including without limitation, its agents,
employees, servants, representatives, parents, subsidiaries, affiliates, officials, directors, officers, shareholders, attorneys,
divisions, branches, units, affiliated organizations, successors, predecessors, contractors, assigns, and all persons acting by,
through, under, or in concert with them, past or present, specifically including Ms. Ireland, kathy ireland Worldwide, Sterling/Winters
Company, or its executives and employees.

 

21INSOLVENCY;
CHANGE OF CONTROL

 

		21.1	If Licensee files a petition in bankruptcy or is adjudicated a bankrupt or if a petition in bankruptcy is filed against Licensee,
or if it becomes dissolved, or becomes insolvent or unable to pay or discharge its liabilities in the ordinary course of business,
or if Licensee assigns the whole or any substantial part of its assets or undertakings for the benefit of creditors or makes an
assignment for the benefit of its creditors or any similar arrangement pursuant to any federal or state law, compulsory or voluntarily,
or if a receiver or other similar officer is appointed for the whole or any part of the assets or undertakings of Licensee or its
business, or if Licensee stops payment to its creditors generally, or ceases or threatens to cease to carry on its business or
any substantial part thereof, Licensor may terminate this Agreement by giving notice to Licensee of its intention to terminate
and such termination shall be effective immediately. Licensor is aware of and consents to Licensee's intention to merge with, or
otherwise be acquired by, another entity ("Parent") so that Licensee will become a wholly owned subsidiary of Parent
(the "Merger") and that following the Merger the current shareholders of Licensee will remain in control of the post
Merger entity. Following the Merger nothing herein set forth shall prevent Licensee from acquiring or being acquired by another
entity or entering into any corporate transaction deemed to be favorable to Licensee, its shareholders or shareholders of Parent
provided no such transaction shall be permitted hereunder with any purchaser, acquirer or merger candidate or any other third party
that is engaged in the business of marketing or selling fire arms, tobacco or alcohol or is engaged in adult entertainment or providing
other products and services associated with sexual, prurient or illicit activity that in the reasonable judgment of Licensor may
demean or cause harm to the Brand (each a "Proscribed Transaction" in the singular and, if in the plural, "Proscribed
Transactions"). In the event a Proscribed Transaction, Licensor may elect to terminate the License. In the event this Agreement
is so terminated, and other than as set forth in paragraph 26.2 below, Licensee, its receivers, representatives, trustees, agents,
administrators, successors, and/or assigns shall have no right to sell, exploit, or in any way deal with or in any Licensed Products
covered by this Agreement or any related advertising, marketing, promotional, and display materials, including without limitation
cartons, containers, packing, and wrapping materials, except with and under the special consent and instructions of Licensor in
writing, which they shall be obligated to follow.

 

    	-26-

    	 

    

  

		21.2	In the event this Agreement is so terminated under this Section 21 or is terminated under Section 22, Licensee, its receivers,
representatives, trustees, agents, administrators, successors, and/or assigns shall have no right to sell, exploit, or in any way
deal with or in any Licensed Products covered by this Agreement or any related advertising, marketing, promotional, and display
materials, including without limitation cartons, containers, packing, and wrapping materials, except with and under the special
consent and reasonable instructions of Licensor in writing, which they shall be obligated to follow, provided nothing herein set
forth shall restrict the rights of Licensee to sell its inventory following termination according to the provisions of paragraph
26.2 below.

 

22TERMINATION

 

		22.1	Except as otherwise provided herein, in the event either party breaches or fails to perform any of its material duties and
obligations pursuant to the terms of this Agreement, the non-breaching party shall have the right to terminate this Agreement upon
thirty (30) days' notice in writing, and such notice of termination shall become effective unless the breaching party shall remedy
the breach within the thirty (30) day period to the reasonable satisfaction of the non-breaching party. The Parties agree to make
a reasonable effort to resolve any disputes or breaches prior to exercising the right of termination.

 

		22.2	Termination of this Agreement shall be without prejudice to any rights, which Licensor may otherwise have against Licensee
or which Licensee may have against Licensor. Upon the termination of this Agreement, notwithstanding anything to the contrary herein,
all royalties on sales theretofor made and collected and any other monies owed, shall become immediately due and payable, and all
rights and licenses granted hereunder shall cease and revert to Licensor. Other than as may be permitted by paragraph 26.2 below,
Licensee shall immediately cease and desist from using the Licensed Marks in any way. Unless otherwise stated in this Agreement,
and except as may be permitted by paragraph 26.2 below, Licensee shall have no right to sell, exploit, or in any way deal with
or in any Licensed Products covered by this Agreement or any related advertising, marketing, promotional, and display materials,
including without limitation cartons, containers, packing, and wrapping materials, except with and under the special consent and
instructions of Licensor in writing, which they shall be obligated to follow. Licensee shall immediately return any and all Confidential
Information of Licensor to Licensor, as well as marketing and advertising materials bearing the Licensed Marks and Licensor shall
immediately return any and all confidential or non-public information and materials of Licensee to Licensee.

  

    	-27-

    	 

    

  

		22.3	Upon the natural expiration or termination of this Agreement, neither Party shall make any publicly disparaging comments regarding
the other or its business, whether written, oral, or electronic. This provision shall survive the expiration or termination of
this Agreement. However, nothing herein shall limit either Party’s right to arbitration or other judicial remedies as set
out in this Agreement.

 

		22.4	Licensee acknowledges that a failure (except as otherwise expressly provided herein) to cease the manufacture, sale, transmission,
broadcast or distribution of the Licensed Products upon the terminations or expiration of this License Agreement will result in
immediate and irreparable damage to Licensor and Ms. Ireland. Licensee further acknowledges that there is no adequate remedy at
law for such failure to cease manufacture, sale or distribution, and in the event of such failure, Licensor and / or Ms. Ireland
shall be entitled to equitable relief and such further relief as a court or agency with jurisdiction may deem just and proper.

 

		22.5	Upon termination or expiration of this License Agreement, all of Licensee's rights granted
                                                              hereunder including all Licensee's rights and interest in and to the Licensed Marks including but not limited to,  ,
                                                              copyright, trademark, service mark, trade dress and all additions and changes thereto, trade secret rights, and goodwill
                                                              relating to the Licensed Marks shall revert to Licensor. Each Party agrees with the other promptly to execute all documents
                                                              that may be reasonably necessary to effect the rights of the other in their respective intellectual property. This right and
                                                              obligation shall survive the terminations or expiration of this Agreement.

 

23FORCE
MAJEURE

 

		23.1	The Parties shall be released from their obligations hereunder, and this Agreement shall terminate in the event that governmental
regulations or regulatory causes beyond the control of the Parties render performance impossible for a period of three months or
more, and one Party so informs the other in writing of such causes and its desire to be so released. In such event, all royalties
that are then due and all other monies then owing, including pro rated minimum annual royalties for that contract year shall become
immediately due and promptly payable to Licensor. In the event of causes arising out of a state or national emergency or war including
nature disaster or other acts of God all parties are released of their obligations immediately.

 

24NOTICES

 

		24.1	Any notice, communication, statement, payment, or legal service of process required or permitted under this Agreement shall
be in writing and shall be effective when hand delivered; or on the date when the notice, communication, statement, payment, or
legal service of process is transmitted by confirmed electronic facsimile (with a confirmation copy sent by mail); or the day after
the notice, communication, statement, payment, or legal service of process is sent by reputable overnight air courier service (e.g.,
Federal Express). All such communications shall be sent to the Parties at the notice addresses listed below or to such other persons
and the Parties to each other may designate notice addresses as in writing.

 

	If to Licensor:	kathyireland Worldwide

                                                                                PO
Box #1410 

Rancho Mirage, CA 92270 

Facsimile: 310 557-1722 

Attention: Erik Sterling 

Email: esterling@sterlingwinters.com
	

 

    	-28-

    	 

    

 

	With
    a copy to:	Mr.
        Tom Hoberman

        FAX:
        310) 550-5220

        Email:
        tt@hjth.com

	 	 
	If
    to Licensee:	NuGene
        Inc.

        720
        Paularino Avenue

        Costa
        Mesa, California 92626

        Facsimile
        No.: 714-641-2646

        Attention:
        Ali Kharazmi

        Email:
        mak41258@aol.com

	 	 
	With
    a copy (not

 constituting 

notice) to:	Mr.
    Aaron A. Grunfeld
	 	Email:
    agrunfeld@grumfeldlaw.com

 

25NEGATION
OF AGENCY

 

		25.1	Licensee is an independent contractor. Nothing contained herein shall be deemed to create an agency, joint venture, franchise,
or partnership relation between the Parties, and neither Party shall so hold itself out. Licensee shall have no right to obligate
or bind Licensor in any manner whatsoever, and nothing contained in this Agreement shall give, or is intended to give, any rights
of any kind to any third person(s).

 

26
ASSIGNABILITY

 

		26.1	This Agreement shall inure to the benefit of Licensor, its successors, and assigns, but will be personal to Licensee, and shall
be assignable by Licensee only with the prior written consent of Licensor. Licensee shall not mortgage, assign, sub-license, or
otherwise encumber this Agreement without the prior written consent of Licensor. Licensor shall be entitled to assign this Agreement
to any third party with notice to Licensee, including any such assignment in connection with the sale or transfer of Licensor’s
business.

 

		26.2	If this Agreement is terminated for any reason, Licensee shall have a period of six (6) months from the effective date of termination
in which to sell off its inventory of Licensed Products, subject to the terms and conditions of this Agreement, including paying
applicable Royalties.

 

27MODIFICATION
AND WAIVER

 

		27.1	Except as otherwise provided herein, no agreement or understanding
                                         purporting to add to or to modify the terms and conditions of this Agreement shall be
                                         binding unless agreed to by the Parties in writing. Any terms and conditions set forth
                                         in any forms used by the Parties, which are in conflict with the terms and conditions
                                         of this Agreement, shall be void and have no effect. The Parties further agree that the
                                         Exhibits to this Agreement may be modified, amended, altered, and/or supplemented
                                         from time to time in writing signed by authorized representatives of the Parties.

 

    	-29-

    	 

    

 

		27.2	It is agreed that no waiver by either Party hereto or any breach or default of any of the provisions set forth herein shall
be deemed a waiver as to any subsequent and/or similar breach or default.

 

28GOVERNING
LAW

 

		28.1	This Agreement shall be construed in accordance with and the laws of the State of California shall govern all disputes relating
hereto without giving effect to any conflicts of law provisions.

 

29CONFIDENTIALITY

 

		29.1	The Parties agree that the terms, conditions, and subject matter
                                         of this Agreement constitute confidential and proprietary information belonging to Licensor
                                         and where applicable constitute confidential and proprietary information belonging to
                                         Licensee. Each Party agrees not to divulge any confidential and proprietary information
                                         pertaining to the other Party or this Agreement to any third party without prior written
                                         consent of the other Party. Each of Licensee and Licensor shall take any and all lawful
                                         measures to prevent the unauthorized use and/or disclosure of such confidential information
                                         belonging to the other, and to prevent unauthorized persons or entities from obtaining
                                         or using such information. Each Party further agrees to refrain from directly or indirectly
                                         taking any action, which would constitute or facilitate the unauthorized use or disclosure
                                         of such confidential information belonging to the other. Each Party may disclose such
                                         confidential and proprietary information to its officers, directors, employees, agents,
                                         and authorized representatives to the extent necessary to enable each Party to perform
                                         its obligations under this Agreement, provided that said officers, directors, employees,
                                         agents, and/or authorized representatives execute an appropriate confidentiality agreement
                                         reasonably satisfactory to the other Party, which by its terms shall be enforceable by
                                         injunctive relief. Each Party shall be liable to the other shall be liable for any unauthorized
                                         use and disclosure of such confidential information by its officers, directors, employees,
                                         agents, and authorized representatives, including without limitation its attorneys and
                                         accountants. The Parties further agree that any breach or threatened breach of this Section
                                         would cause irreparable harm to to the Party whose confidential information has been
                                         so
                                         disclosed or so compromised, that a remedy at law or in damages would be inadequate,
                                         and that the provisions of this Section may be enforced by way of injunctive relief in
                                         addition to any other rights available to Licensor in law or in equity. Notwithstanding
                                         the foregoing or anything else herein set forth, Licensee or its parent shall be permitted
                                         to attach a copy of this Agreement, and all attachments thereto, as an exhibit to filings
                                         that are made with the United States Securities and Exchange Commission, and to disclose
                                         the general contents of this Agreement to the extent it is advised that such disclosure
                                         is necessary or appropriate under applicable federal or state securities laws or other
                                         applicable regulations

 

		29.2	For purposes of this Agreement, “confidential and proprietary information” includes, but is not limited to, the
terms, conditions, and subject matter of this Agreement, and Licensor’s or Licensee's business, including any financial,
cost, pricing, and royalty information; product development, business, marketing, promotion, distribution, sales, sales plans,
and strategies; information concerning Licensor’s or Licensee’s product development and intellectual property; information
concerning manufacturing processes and formulas, marketing and efficacy studies, all as they relate to the Licensed Products and
other products of Licensee, or trade secrets. The foregoing confidentiality obligations shall not apply to information that:

 

    	-30-

    	 

    

 

(1)
was previously known to the recipient free of any obligation to keep it confidential;

(2)
was independently developed by recipient; or (3) is or becomes publicly available by means other than the unauthorized
disclosure by recipient.

  

		29.3	In the event that any judicial or regulatory authority requests or requires disclosure of any Confidential Information of the
other Party, the receiving Party shall promptly notify the disclosing Party of the requested or required disclosure and shall cooperate
with the disclosing Party in any effort to avoid or limit such disclosure, but not to extent of delaying any time period within
which disclosure is required to be made.

 

30   ENTIRE AGREEMENT
AND ADMISSIBILITY

 

		30.1	This Agreement constitutes the complete understanding between the Parties and supersedes any and makes void any and all prior
agreements, promises, representations, or inducements, no matter their form, concerning the subject matter of this Agreement. The
Parties desire that this Agreement shall represent a single and completely integrated contract expressing the entire agreement
of the Parties with respect to the subject matter of this Agreement. No promises, agreements, or modifications to this Agreement
made subsequent to the execution of this Agreement by the Parties shall be binding unless reduced to writing and signed by authorized
representatives of the Parties. The Parties to this Agreement agree that this Agreement may be used as evidence in any subsequent
proceeding in which any Party alleges a breach of this Agreement or seeks to enforce its terms, provisions, or obligations.

 

31   SEVERABILITY

 

		31.1	Whenever possible, each provision of this Agreement shall be interpreted in such a manner to be effective and valid under applicable
law. Should any of the provisions or terms of this Agreement be determined illegal, invalid, or unenforceable by any court of competent
jurisdiction, validity of the remaining parts, terms, or provisions shall not be affected thereby, and said illegal, invalid, or
unenforceable part, term, or provision shall be deemed not to be a part of this Agreement.

 

32   RECITALS AND SECTION HEADINGS

 

		32.1	The terms of this Agreement are contractual, not a mere recital, and are the result of joint negotiations between, and joint
drafting by, the Parties, and are therefore not to be construed in favor of or against either Party. All recitals are incorporated
by reference into this Agreement. Caption and paragraph headings are used for convenience and reference only, are no part of this
Agreement, and shall not be used in interpreting, construing, defining, limiting, extending, or describing the scope of this Agreement,
or any provision hereof, in any way.

 

33   ATTORNEY FEES AND
COSTS

 

		33.1	Should any action be necessary to enforce the terms of this Agreement, the prevailing Party will be entitled to recover reasonable
attorneys’ fees and costs.

 

34   EXECUTION
OF COUNTERPARTS

 

		34.1	This Agreement may be executed in two or more duplicate bond or facsimile counterparts, each of which shall be considered an
original, but all of which together shall constitute one and the same instrument, and in pleading or proving any provision of the
Agreement, it shall not be necessary to produce more than one such counterpart.

 

    	-31-

    	 

    

 

35  EQUITABLE RELIEF

 

		35.1	The Parties acknowledge that the subject matter of this Agreement relates to services and rights, which are extraordinary and
unique and which cannot be replaced or adequately compensated in money damages, and any breach by Licensee or Licensor of this
Agreement will cause irreparable injury to the other.

 

36   ARBITRATION

 

		36.1	The Parties agree that any and all disputes, controversies or claims arising out of, regarding, or in any way relating to the
interpretation, application, or enforcement of this Agreement, or any matter reasonably related thereto, shall be handled by way
of arbitration and administered by and in accordance with the JAMS Streamlined Arbitration Rules and Regulations (the “JAMS
Rules”) of the Judicial Arbitration and Mediation Service in effect at the time of any such proceedings. Such arbitration
shall be the sole, exclusive, and final remedy for resolving any such claims and disputes. Judgment on the final award rendered
by the arbitrator may be entered into in any court of competent jurisdiction and shall be final and binding upon the Parties.

 

		36.2	In the event the Parties cannot agree on an arbitrator within ten (10) days, the arbitrator shall be appointed by the Parties
in the following manner JAMS, and/or another alternative dispute resolution provider agreed upon by the Parties, shall furnish
the Parties with a list of potential qualified arbitrators. For purposes of this Section, a “qualified arbitrator” shall
mean a retired judge of a superior or appellate court or an experienced attorney agreed upon by the Parties. If any Party objects
to all the names on the list, AAA, and/or another alternative dispute resolution provider agreed upon by the Parties, shall provide
the Parties with an alternative list of potential qualified arbitrators; provided, however, that each Party shall be entitled to
so object only once. Once the Parties have agreed upon a particular list, or a list is furnished pursuant to the preceding sentence,
the Parties shall alternately eliminate unacceptable arbitrators until only one name remains. The remaining person shall be appointed
arbitrator. The Parties agree to draw lots to decide which Party shall remove the first name from the list of arbitrators. Should
a Party whose turn it is to eliminate an unacceptable arbitrator fail to do so within twenty-four (24) business hours of the written
request of the other Party, then the choice of the other Party of an arbitrator then remaining on such list shall be binding on
the Parties. All costs of the arbitration, including the cost of any record or transcript of the arbitration proceedings, all administrative
fees, the fee of the arbitrator, and all other fees and costs shall initially be borne equally by the Parties, provided, however,
that the arbitrator shall award the prevailing Party its reasonable attorneys’ fees, expenses and costs, including all costs
of arbitration.

 

		36.3	The arbitrator shall not extend, modify, or suspend any of the terms of this Agreement. The arbitration and all proceedings
related thereto shall be deemed private and confidential and, subject to the provisions of paragraph 29.1, shall not be disclosed
to the public by either the arbitrator or the Parties to the arbitration. If the rules of AAA, JAMS or another agreed upon alternative
dispute resolution provider differ from those of this Section, the provisions of this Section shall control.

 

    	-32-

    	 

    

 

		36.4	Notwithstanding the foregoing, the Parties may seek provisional relief, including a preliminary injunction or temporary restraining
order, in any federal or state court of competent jurisdiction located in Los Angeles, California, without prejudice to the above-described arbitration procedures, if in that Party’s sole judgment such provisional relief is necessary to avoid irreparable
injury or to preserve the status quo. Nevertheless, the arbitration procedure set forth in this Section is intended to be the sole
and exclusive method of resolving any claims arising out of, relating to, or regarding this Agreement.

 

(remainder
of the page intentionally left blank –  signature page follows)

 

    	-33-

    	 

    

 

IN WITNESS
WHEREOF, the Parties hereto have caused this instrument to be duly executed as of the day and year first above written.

 

kathy ireland WORLDWIDE, Inc.,

a California Corporation

 

	By:	/s/ Kathy Ireland	 
	Name:	 	 
	Title:	 	 

 

November 4th,
2014

 

NuGene
Inc., a California corporation

 

	By:	/s/ Ali Kharazmi	 
	Name: Ali Kharazmi	 
	Title: President	 

 

November 4,
2014

 

    	-1-

    	 

    

 

EXHIBIT
A

 

Licensed
Marks

 

		1.	Kathy Ireland likeness, only as approved in writing by Licensor and only in connection with the Licensed Products specified
in Exhibit B to this Agreement and only as shown in the following specimen(s): Specimen(s) are located on Examples on Brand
Partner Resource link; on kathyireland.com - upon your signature a password will be provided

 

		2.	kathy ireland logo(s) only for the Licensed Products
specified in Exhibit B to this Agreement and only as shown in the following specimen(s):

 

Examples
on Brand Partner Resource link; on kathyireland.com; upon your signature a password will be provided

 

Other
supporting brands as may be designated by Licensor in writing from time to time

 

    	- 1 -

    	 

    

 

EXHIBIT
B

 

LICENSED PRODUCTS:

 

Each of the
following products of Licensee containing stem cell derived or containing biologically active or biologically derived ingredients:
NuGene Face Wash, NuGene Universal Cream, NuGene Universal Serum, NuGene Light and Bright, NuGene Eye Serum, NuGene Anti-Hair Loss
Serum, NuGene Regenerative Shampoo & Conditioner, NuGene FaceMask, NuGene Melasma Serum, NuGene Acne Serum, NuGene Revitalizing
Night Cream, NuGene Toner NuGene Body Lotion, NuGene Specialty Soap, NuGene Neck & Decollete Lotion, Advanced Infusion Serums
and other age defying products that are stem cell derived or which contain biologically active or biologically derived ingredients.

 

CHANNELS OF DISTRIBUTION:

 

Approved channels
of distribution include Web Advertising and, Physicians and Spas, Retail Stores (other than those excluded in the paragraph which
immediately follows), Duty Free Shops; retail websites owned and operated by retailers in the above channels, Licensee’s
websites, websites maintained by American Express alone or with partners such as vente-prive, as well as dermstore.com and Alphaeon.com;
Nordstrom's, Sephora, Dillards, Bloomingdales, Saks, Neiman Marcus, Bergdorf Goodman, Macy's and other categories of “Macy's
and above” stores, as well as all military and post exchange stores.

 

Price Club,
Sam’s Club, Fedco and other “Club” type stores are currently excluded but will be permitted commencing any year
in which Licensee achieves sales of $5 million or more.

 

Mass Market,
discount and Low Tier Department Stores (i.e., Wal-Mart, K-Mart, Target, and Sears), are excluded from the approved Channels of
Distribution under this Agreement. Internet Retailers will be handled on an individually approved by Licensor basis, and except
as so proscribed herein, all other channels shall be permitted.

 

Licensed
Products bearing the “kathy ireland” mark may not be sold in the home improvement, drugstore, or food and grocery Channels
of Distribution.

 

Televised retail
channels (HSN, QVC, etc.) are specifically excluded from the approved Channels of Distribution.

 

    	- 2 -

    	 

    

 

EXHIBIT C

 

CODE
OF CONDUCT

 

 

1. PURPOSE:
[LICENSEE] is committed to using only manufacturers to strive to conduct business in a highly professional and ethical manner.
This document outlines those commitments each facility makes in respect to its compliance with applicable law and tis personal
practices and policies.

 

 

2. CHILD
LABOR: The facility agrees not to use child labor in the manufacturing, or distribution of the Goods. The term “child”
refers to a person younger than the local legal minimum age for employment or the age for completing compulsory education; provided,
however, in no event shall the Facility use any person below the age of (15) fifteen. The Facility also agrees to comply with all
other Laws applicable to employees, regardless of the age of an employee.

 

 

3.
FORCED LABOR: The Facility agrees to employ only persons whose presence is voluntary. The Facility agrees not to use any forced
or involuntary labor, whether prison, bonded, indentured or otherwise.

 

 

4. ABUSE
OF LABOR: The Facility agrees to treat each employee with dignity and respect and not to use corporal punishment, threats of violence,
or other forms of physical, sexual, psychological or verbal harassment or abuse.

 

 

    	- 3 -

    	 

    

 

5.
NON-DISCRIMINATION: The Facility agrees not to discriminate in hiring and employment practices, including salary, benefits, advancement,
discipline, termination, or retirement on the basis of race, religion, age, nationality, social or ethnic origin, sexual orientation,
gender, political opinion or disability.

 

 

6. ASSOCIATION:
The Facility agrees to follow employees to organize and bargain collectively without penalty or interference in accordance with
local Laws.

 

 

7. WAGES,
DENEFITS AND WORKING HOURS: The facility recognizes that wages are essential to meeting employee’s basic needs. The Facility
agrees to comply, at a minimum, with all applicable wages and hour Laws, including minimum wage, overtime hours, maximum hours,
piece rates and other elements of compensation and shall provide legally mandated benefits.

 

 

8. HEALTH
AND SAFETY: The Facility agrees to provide employees with a safe and healthy workplace environment in accordance with all applicable
Laws, ensuring at a minimum, reasonable access to potable water and sanitary facilities, fine safety and adequate lighting and
ventilation. The Facility also agrees to ensure that the same standards of health and safety are applied to any housing it provides
for employees.

 

 

9. COMPLIANCE:
The Facility agrees to take appropriate steps to ensure that the provisions of the COC are communicated to its employees, including
by prominent posting a copy of this COC in the local language on one or more bulletin boards in places readily accessible to employees
at all times.

 

    	- 4 -

    	 

    

 

 

10. ENVIRONMENT:
Business partners should share our concern for the environment and adhere to their local and national laws regarding the protection
and preservation of the environment.

 

 

11.
LEGAL REQUIREMENTS: Business partners should be in compliance with all legal requirements involved in conducting the business.

 

 

12. Our Business
Partners are required to provide full access to their facilities and those of their manufacturers, vendors and subcontractors,
and to release records relating to employment practices. We may conduct on-site inspections of facilities to monitor the standards
and assure the quality of our products.

 

 

Please report Violations Anonymously by emailing to: esterling@sterlingwinters.com

 

	
        esterling@sterlingwinters.com:

        
	 

 

    	- 5 -

    	 

    

 

EXHIBIT
D

 

INTENTIONALLY BLANK

 

    	- 6 -

    	 

    

 

EXHIBIT
E

 

Approved
Royalty Report Form

 

Examples on Brand Partner Resource link;

 

On kathyireland.com; upon your signature
a password will be provided

 

    	 

    	 

    

 

EXHIBIT F

 

Approved
Licensing Statement

 

Manufactured
and distributed by.

 

A
member of the

kathy
ireland Worldwide Partnership.

for
kathy ireland Worldwide.

 

Website

 

www.kathvireland.com

 

Approved
Mission Statement

 

“...finding
solutions for families,

especially
busy moms.”TM

 

“...encontrando
soluciones para familias,

especialmente
madres ocupadas.”TM

 

“...finding solutions for people
in love.”TM

 

“...finding solutions for people in Business.”TM

 

    	 

    	 

    

 

EXHIBIT
G

 

REQUIRED INSURANCE CERTIFICATE

 

Under Description of Operations state the following: 

 

Certificate Holder Kathy Ireland, kathy ireland Worldwide,
The Sterling/Winters

 

Company, subsidiaries, affiliates; their directors, officers
and employees are named additional insured with regards to liability arising out of operations of the named insured.

 

The Certificate Holder should be listed as:

 

kathy ireland Worldwide

PO Box #1410

Rancho Mirage, CA., 92270

 

Send copies of Certificate to:

 

kathy ireland Worldwide

Erik Sterling

FinancialCommittee@sterlingwinters.com

 

Jane Hirata

JHirata@mmibi.com

Momentous Insurance Brokerage, Inc.

 

    	 

    	 

    

 

EXHIBIT
H

 

LICENSEE’S PRINCIPAL SUPPLIERS

 

To be supplied
two business days following full execution of this Agreement by the Parties.

 

    	 

    	 

    

 

-
END OF CONTRACT-Exhibit 10.6

 

BUSINESS TRANSFER AND INDEMNITY AGREEMENT

 

by
and between 

 

BLING MARKETING,
INC.,

 

a Nevada corporation,

 

and,

 

Dena Kurland

 

Dated:
As of December 29, 2014

 

BMI/NuGene Business Transfer-Indemnity

 

    	 

    	 

    

 

BUSINESS TRANSFER AND INDEMNITY AGREEMENT

 

THIS BUSINESS
TRANSFER AND INDEMNITY AGREEMENT (this “Agreement”), dated as of December 29, 2014, is entered into by and
among Bling Marketing, Inc., a Nevada corporation (“BMI” or “Company”), Dena Kurland, an
individual (“Buyer”), and is made with reference to the following matters:

 

RECITALS

 

A.           BMI
is engaged in marketing affordable jewelry at wholesale (the “Jewelry Operations”).

 

B.           The
BMI Jewelry Operations are further described in the BMI's most recent quarterly reports on Form 10-Q for the periods ended March
31, 2014, June 30, 2014 and September 30, 2014 as filed with the Securities and Exchange Commission (“SEC”) on May
5, 2014 and August 13, 2013, and October 27, 2014 respectively.

 

C.           
BMI has entered into that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of December
__, 2014, with NuGene, Inc., a California corporation (“NuGene”), and NG Acquisition, Inc., a California
corporation wholly owned by BMI (“Acquisition Sub”), pursuant to which Acquisition Sub will be merged with and
into NuGene (the “Merger”), with NuGene as the surviving corporation and a wholly-owned subsidiary of BMI.

 

D.           
It is a covenant under the Merger Agreement that upon or following effectiveness of the Merger (the “Merger Closing”
and the date of the Merger Closing, the “Merger Closing Date”) that BMI (i) sell or commit to sell to Buyer
and that Buyer acquire or commits to acquire from BMI all of the Jewelry Operations (inclusive of cash, inventories, accounts
payable, accrued expenses and loan from related party in amount of $22,039 at September 30, 2014), (ii) acquire from the Buyer
all of the shares of BMI owned by Buyer amounting to 15,000,000 shares of common stock (the "Indemnity Shares")
before giving effect to a 15:04 : 1 forward share split in the form of a stock dividend (the "Stock Split"), (iii)
pay to Buyer an aggregate of $350,000 and that (iv) BMI receives or obtains from Buyer indemnities that hold BMI, NuGene and the
shareholders or equity holders of NuGene as of the Closing (the “Existing NuGene Shareholders”) harmless for
any and all liabilities of BMI in existence, arising during, or relating to the period prior to the Closing (such liabilities being,
the “Assumed Liabilities”), excepting those liabilities expressly set forth on Schedule 1 attached hereto which
such liabilities shall remain the sole responsibility of BMI (the “Retained Liabilities”).

 

E.           It
is the express intent of the parties hereto that NuGene and the NuGene Shareholders shall be third-party beneficiaries of Buyers'
obligations in respect of the Indemnified Liabilities under this Agreement as if NuGene and the NeGene Shareholders were parties
to this Agreement.

 

BMI/NuGene Business Transfer-Indemnity

 

    	 

    	 

    

 

NOW, THEREFORE, in
consideration of the mutual promises and covenants set forth herein and for such other good and valuable consideration, the adequacy
and receipt of which are hereby acknowledged, the parties hereby agree as follows:

 

ARTICLE I

DEFINITIONS

 

1.1           Specific
Definitions. When used in this Agreement, the following terms shall have the following meanings:

 

“Affiliate”
shall mean, with respect to any Person (i) a Person directly or indirectly controlling, controlled by or under, control with
such Person, (ii) a Person owning or controlling 10% or more of the outstanding voting securities of such Person or (iii) an
officer, director, general partner, member or manager of such Person, or a member of the immediate family of an officer, director,
general partner, member or manager of such Person. When the Affiliate is an officer, director, partner or manager of such Person
or a member of the immediate family of an officer, director, general partner, member or manager of such Person, any other Person
for which the Affiliate acts in that capacity shall also be considered an Affiliate. For these purposes, control means the possession,
direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through the
ownership of voting securities, as trustee or executor, by contract or otherwise.

 

“Agreement”
shall mean this Business Transfer And Indemnity Agreement, including all schedules thereto, as the same may hereafter be amended,
modified or supplemented from time to time.

 

“Applicable Law”
shall mean, with respect to any Person, any domestic or foreign, Federal, state or local statute, law, ordinance, rule, administrative
interpretation, regulation, order, writ, injunction, directive, judgment, decree or other requirement of any Authority applicable
to such Person or any of its Affiliates or ERISA Affiliates or any of their respective properties, assets, officers, directors,
general partners, managers, employees, consultants or agents (in connection with such officer’s, director’s, general
partner’s, manager’s, employee’s, consultant’s or agent’s activities on behalf of such Person or
any of its Affiliates or ERISA Affiliates).

 

“Assumed Liabilities”
shall have the meaning specified in paragraph D of Recitals.

 

“Authority”
shall mean any governmental, regulatory or administrative body, agency or authority, any court or tribunal of judicial authority,
any arbitrator or any public, private or industry regulatory authority, whether Federal, state, local or foreign.

 

“Business Day”
shall mean a day other than a Saturday, Sunday or other day on which commercial banks in Los Angeles, California are authorized
or required by Applicable Law to close.

 

“Buyer"
shall have the meaning set forth in the introductory paragraph of this Agreement.

 

NUGENE/BMI

Business Transfer Indemnity Agreement

 

    	2

    	 

    

 

“Buyer Documents”
shall mean this Agreement and all other agreements, instruments and certificates to be executed and delivered by Buyer in connection
with this Agreement.

 

“Closing”
shall mean the consummation of the transactions contemplated in this Agreement.

 

“Closing Date”
shall mean the date upon which the Closing occurs.

 

“Code”
shall mean the Internal Revenue Code of 1986, as the same may hereafter be amended from time to time. Any reference to a specific
section of the Code shall refer to the cited provisions as the same may be subsequently amended from time to time, as well as to
any successor provision(s).

 

“BMI” shall
have the meaning set forth in the introductory paragraph hereof.

 

“BMI Documents”
shall mean this Agreement and all other agreements, instruments and certificates to be executed by BMI in connection with this
Agreement.

 

“BMI Indemnified
Parties” shall have the meaning specified in Section 8.2.

 

“Contracts”
of a Person shall mean all contracts, agreements, warranties, guaranties, indentures, bonds, options, leases, subleases, easements,
mortgages, plans, collective bargaining agreements, licenses, commitments or binding arrangements of any nature whatsoever, express
or implied, written or unwritten, and all amendments thereto, entered into or binding upon that Person or to which any property
of that Person may be subject.

 

“Effective Date
of the Closing” shall have the meaning specified in Section 3.1.

 

“Effective Time”
shall mean 12:01 a.m. Los Angeles time on the Effective Date of the Closing.

 

“Indemnity Shares”
shall have the meaning specified in paragraph D of Recitals.

 

“Jewelry Operations”
shall have the meaning specified in paragraph B of Recitals.

 

“Lien”
shall mean any lien, encumbrance, pledge, mortgage, security interest, lease, charge, conditional sales contract, option, restriction,
reversionary interest, right of first refusal, voting trust arrangement, preemptive right, claim under bailment or storage contract,
easement or any other adverse claim or right whatsoever.

 

“Losses”
shall mean all damages, awards, judgments, assessments, fines, sanctions, penalties, charges, costs, expenses, payments, Taxes,
diminutions in value and other losses, however suffered or characterized, all interest thereon, all costs and expenses of
investigating any claim, lawsuit or arbitration and any appeal therefrom, all actual attorneys’, accountants’ investment
bankers’ and expert witness’ fees incurred in connection therewith, whether or not such claim, lawsuit or arbitration
is ultimately defeated and, subject to ARTICLE VIII, all amounts paid incident to any compromise or settlement of any such
claim, lawsuit or arbitration.

 

NUGENE/BMI

Business Transfer Indemnity Agreement

 

    	3

    	 

    

 

“Merger Closing”
shall have the meaning defined in paragraph D of Recitals.

 

“Merger Closing
Date” shall have the meaning defined in paragraph D of Recitals as set forth above.

 

“Order”
shall mean any decree, order, judgment, writ, award, injunction, rule or consent of or by an Authority.

 

“Person”
shall mean any entity, corporation, company, association, joint venture, joint stock company, partnership, trust, organization,
individual (including personal representatives, executors and heirs of a deceased individual), nation, state, government (including
agencies, branches, departments, bureaus, boards, divisions and instrumentalities thereof), trustee, receiver or liquidator, as
well as any syndicate or group that would be deemed to be a Person under Section 13(d)(3) of the Securities Exchange Act of 1934,
as amended.

 

“Proceeding”
shall have the meaning specified in Section 6.1.

 

“Purchase Price”
shall have the meaning specified in Section 2.2.

 

"Stock Split"
shall have the meaning defined in paragraph D of Recitals as set forth above.

 

“Tax” shall
mean any federal, state, local or foreign tax, charge, fee, levy, deficiency or other assessment of whatever kind or nature (including
without limitation, any net income, gross income, gross receipts, sales, use, value added, ad valorem, transfer, franchise, profits,
license, withholding, payroll, employment, unemployment, excise, estimated, severance, stamp, occupation, real property, personal
property, intangible property, occupancy, recording, minimum, environmental and windfall profits tax, including any liability therefor
as a transferee (including without limitation under Section 6901 of the Code or any similar provision of Applicable Law), as a
result of Treasury Regulation Section 1.1502-6 or any similar provision of Applicable Law, or as a result of any tax sharing or
similar agreement, together with any interest, penalty, addition to tax or additional amount imposed by any Tax Authority. “Taxing”
and Taxable” shall have the correlative meanings.

 

“Transfer Taxes”
shall mean all Taxes (other than Taxes measured on or by net income) incurred or imposed upon Buyer BMI by reason of the transfer
of the Transferred Shares to Buyer pursuant to this Agreement, including sales and use taxes, real property transfer taxes, excise
taxes, and stamp, documentary, filing, recording, permit, license, registration or authorization duties or fees (including penalties
and interest in respect of any of the foregoing).

 

NUGENE/BMI

Business Transfer Indemnity Agreement

 

    	4

    	 

    

 

1.2           Interpretation;
Construction. References in this Agreement to “Articles,” “Sections” and “Schedules,”
shall be to the Articles, Sections and Schedules of this Agreement, unless otherwise specifically provided; where the context or
construction requires, all words applied in the plural shall be deemed to have been used in the singular, and vice versa; the masculine
shall include the feminine and neuter, and vice versa; and the present tense shall include the past and future tense, and vice
versa; the words “herein”, “hereof” and “hereunder” and words of similar import, when used
in this Agreement, shall refer to this Agreement as a whole and not to any particular provision of this Agreement; and except as
otherwise specified in this Agreement, all references in this Agreement (a) to any Person shall be deemed to include such Person’s
permitted heirs, personal representatives, successors and assigns, (b) to any agreement, any document or any other written instrument
shall be a reference to such agreement, document or instrument together with all schedules, attachments and appendices thereto,
and in each case as amended, restated, supplemented or otherwise modified from time to time in accordance with the terms thereof
prior to the Effective Time and (c) to any law, statute or regulation shall be deemed references to such law, statute or regulation
as the same may be supplemented, amended, consolidated, superseded or modified from time to time prior to the Effective Time.

 

ARTICLE II

SALE AND PURCHASE OF EQUITY INTERESTS 

 

2.1           Transfer
of Jewelry Operations . On the terms and subject to the conditions set forth in this Agreement and in reliance
upon the representations and warranties of the parties hereto, at the Closing, BMI shall sell, transfer, convey, assign and deliver
to Buyer, and Buyer shall purchase, acquire and accept from BMI, all of the Jewelry Operations.

 

2.2           Purchase
Price and Other Consideration. In exchange for the Jewelry Operations, Buyer shall (i) assume all liabilities, obligations
and costs of the Jewelry Operations that are owing, existing, contingent, or which have arisen or may have arisen through the date
of this Agreement since inception of the BMI, (ii) indemnify and reimburse the BMI from any and all costs, expense or claims or
other losses incurred by the BMI with respect to any matter of any nature that has or have arisen or may be claimed to have arisen
from the date of the BMI's inception on October 30, 2013 through the Closing Date and (iii) shall transfer and deliver the Indemnity
Shares to the BMI (collectively, the foregoing are the "Jewelry Operations Consideration"). In exchange for the
Jewelry Operations Consideration, BMI shall deliver to the Buyer (i) the Jewelry Operations, together with all assets and liabilities
related thereto, and (ii) $350,000 (the "Purchase Indemnity Consideration") .

 

2.3           Transfer
Taxes. All Transfer Taxes imposed by any Tax Authority with respect to any transaction contemplated by this Agreement (if any)
shall be duly and timely paid by Buyer, who shall also duly and timely file all Tax Returns in connection with such Transfer Taxes.
Buyer shall give a copy of each such Tax Return to BMI for its review with sufficient time for comments prior to filing, and shall
give BMI a copy of such Tax Return as filed, together with proof of payment of the Transfer Tax shown thereon, promptly after filing.

 

ARTICLE III

CLOSING

 

3.1           Time
and Place. The Closing shall take place on the Business Day when all of the conditions precedent to each party’s obligations
hereunder have been satisfied or waived and BMI shall have received the Purchase Price. Notwithstanding the foregoing, the Closing
shall be deemed to be effective following the Merger Closing Date (the “Effective Date of the Closing”).

 

NUGENE/BMI

Business Transfer Indemnity Agreement

 

    	5

    	 

    

 

3.2          Transactions
at the Closing and Post-Closing. At the Closing, the following shall occur:

 

(a)          On
the terms and subject to the conditions of this Agreement, Buyer shall deliver each of the items comprising the Jewelry Operations
Consideration as set forth in Section 2.2 of this Agreement;

 

(b)          BMI
shall deliver assignments and other appropriate documents of transfer to Buyer relating to the Jewelry Operations and shall deliver
the Purchase Indemnity Consideration to the Buyer;

 

(c)          BMI
and Buyer shall deliver, or cause to be delivered, to each other any and all other assignments, documents, instruments and conveyances
as may be reasonably requested to effect the consummation of the transactions contemplated by this Agreement to evidence Buyer’s
interest in and title to the Jewelry Operations and BMI's acquisition of the Indemnity Shares.

 

The foregoing transactions
shall be deemed to occur promptly after the Closing.

 

ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF COMPANY

 

BMI represents and
warrants to Buyer that:

 

4.1          Authority
to Execute and Perform Agreements. BMI has the right, power and authority to
enter into, execute and deliver this Agreement and all other BMI Documents and to transfer, convey and sell to Buyer at the Closing
the Jewelry Operations under the terms of this Agreement.

 

4.2          Due
Authorization; Enforceability. BMI has taken all actions necessary to authorize the execution and delivery of this
Agreement and the performance of the obligations under this Agreement and all other BMI Documents. This Agreement and all other
BMI Documents have been duly and validly executed by BMI and (assuming the due authorization, execution and delivery of Buyer)
constitute the legal, valid and binding obligation of BMI, enforceable against such BMI in accordance with their terms, except
as the same may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar Applicable Laws affecting
creditors’ rights generally or by general equitable principles affecting the enforcement of contracts.

 

4.3          No
Broker. No financial advisor, broker, finder, agent or similar intermediary has acted for or on behalf of BMI in connection
with this Agreement or the transactions contemplated herein, and no financial advisor, broker, finder, agent or similar intermediary
is entitled to any broker’s or finder’s or similar fee or other commission in respect of such transactions based on
any agreement, arrangement or understanding with BMI or any action taken by BMI.

 

NUGENE/BMI

Business Transfer Indemnity Agreement

 

    	6

    	 

    

 

ARTICLE V

REPRESENTATIONS AND WARRANTIES

OF BUYER REGARDING COMPANY AND BMI BUSINESS

 

Buyer, represents and
warrants to BMI, for the benefit of BMI, NuGene and the NuGene Shareholders:

 

5.1          Authority;
Due Authorization.

 

(a)          Authority
to Execute and Perform Agreements. Buyer has all requisite power, authority and approvals required to enter into, execute and
deliver this Agreement and all of the other Buyer Documents and to perform fully Buyer’s obligations hereunder and thereunder.

 

5.2          Due
Authorization; Enforceability. Buyer has taken all individual and corporate actions necessary to authorize Buyer to enter into
and perform fully his obligations under this Agreement and all of the other Buyer Documents to be executed by him and to consummate
the transactions contemplated herein and therein. This Agreement has been duly and validly executed by the Buyer and (assuming
due authorization, execution and delivery by BMI) constitutes the legal, valid and binding obligation of Buyer, enforceable against
each of the Buyer in accordance with its terms, except as the same may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium or similar Applicable Laws affecting creditors’ rights generally or by general equitable principles affecting
the enforcement of contracts.

 

5.3          Merger
Agreement Representations and Warranties. Buyer hereby represents and warrants, for Buyer’s own account, all of the representations
and warranties made by, or in respect of, BMI pursuant to the Merger Agreement, as if such representations and warranties are expressly
set forth herein.

 

5.4         Covenant
of Cooperation. Following the Merger Closing, Buyer will cooperate in good faith, and will assist the Company in connection,
with all year end financial statements, audits, filings with the Securities and Exchange Commission, and BMI’s federal and
state tax returns insofar as they may relate to the operations of the Company through closing of this Agreement.

 

ARTICLE VI

CONDITIONS PRECEDENT TO THE OBLIGATION

OF EACH PARTY TO CLOSE

 

The obligations of
BMI and Buyer to consummate the transactions contemplated herein shall be subject to the fulfillment, at or prior to the Closing,
of each of the conditions set forth below (any of which may be waived by the parties in whole or in part):

 

NUGENE/BMI

Business Transfer Indemnity Agreement

 

    	7

    	 

    

 

6.1          No
Action or Proceeding. The consummation of the transactions contemplated herein shall not violate any Applicable Law.
Further, no temporary restraining Order, preliminary or permanent injunction, cease and desist Order or other legal restraint preventing
the consummation of the transactions contemplated herein, or imposing material damages in respect thereof, shall be in effect,
nor shall there be any action or proceeding pending or threatened by any Person which seeks any of the foregoing or seeks to impose
conditions which would be materially burdensome upon the business of BMI and which presents a substantial risk that the
relief sought will be granted.

 

ARTICLE VII

CONDITIONS PRECEDENT TO THE OBLIGATION

OF BUYER TO CLOSE

 

The obligation of Buyer
to consummate the transactions contemplated herein shall be subject to the fulfillment, at or before the Closing Date, of each
of the conditions set forth below (any of which may be waived by Buyer in whole or in part):

 

7.1          Representations
and Warranties. The representations and warranties of BMI contained in this Agreement and in each other BMI Document
shall have been true and correct when made and shall be true and correct in all material respects on and as of the Closing Date
with the same force and effect as though made on and as of the Closing Date, other than such representations and warranties as
are made as of another specified date, which shall be true and correct as of such date, provided, however, that if any portion
of any representation or warranty is already qualified by materiality, for purposes of determining whether this Section 7.1
has been satisfied, that portion of such representation or warranty as so qualified must be true and correct in all respects. At
the Closing, BMI shall have delivered to Buyer a certificate to such effect signed by an officer of BMI and addressed to Buyer.

 

7.2          Performance
of Covenants. Each obligation of BMI to be performed by BMI on or before the Closing Date pursuant to the terms of this
Agreement and each other BMI Document shall have been duly performed on or before the Closing Date. At the Closing, BMI shall have
delivered to Buyer a certificate to such effect signed by an officer of BMI and addressed to Buyer.

 

ARTICLE VIII

INDEMNIFICATION

 

8.1          Indemnification
by BMI. BMI shall indemnify, defend and hold harmless  Buyer, from and against any and all Losses which may be
incurred or suffered by Buyer and which may arise out of or result from:

 

(a)          any
breach of any representation, warranty, covenant or agreement of the BMI contained in this Agreement and

 

(b)          any
and all actions, suits, proceedings, claims, demands, assessments, judgments, costs and expenses, including, without limitation,
reasonable legal fees and expenses, incurred in enforcing this indemnity and the indemnity obligations of BMI set forth
elsewhere in this Agreement.

 

NUGENE/BMI

Business Transfer Indemnity Agreement

 

    	8

    	 

    

 

Notwithstanding anything
to the contrary contained in this Agreement, BMI’s obligation to indemnify Buyer shall cease immediately upon the Closing.

 

8.2          Indemnification
by Buyer. Buyer shall indemnify, defend and hold harmless (i) BMI, (ii) NuGene, (iii) each of their respective Affiliates,
and (iv) each of their respective stockholders including, without limitation the Existing NuGene Shareholders, members, partners,
directors, officers, managers, employees, agents, attorneys and representatives (collectively, the “BMI Indemnified Parties”),
from and against any and all Losses which may be incurred or suffered by any BMI Indemnified Party and which may arise out of or
result from:

 

(a)          any breach of
any representation, warranty, covenant or agreement of Buyer contained in this Agreement, the Merger Agreement or in any other
BMI Document;

 

(b)          any breach
of any representation, warranty, covenant or agreement of BMI contained in the Merger Agreement;

 

(c)          all
activities, actions and omissions to act of BMI (including for purposes hereof, and BMI’s respective Affiliates, stockholders,
members, partners, directors, officers, managers, employees, agents, attorneys and representatives) arising prior to the Closing,
regardless of whether or not any Loss related to any such activity, action or omission to act shall occur after the Closing; and

 

(d)          any
and all actions, suits, proceedings, claims, demands, assessments, judgments, costs and expenses, including, without limitation,
reasonable legal fees and expenses, incurred in enforcing this indemnity and the indemnity obligations of Buyer set forth elsewhere
in this Agreement.

 

In connection with
the foregoing, Buyer agrees and covenants that, notwithstanding Buyer’s indemnification obligations set forth herein, it
is the intent of the parties hereto that Buyer is and shall continue to be the direct and primary obligor for all of the Assumed
Liabilities and Buyer further agrees and covenants that it shall cause all such Assumed Liabilities to be fully satisfied and discharged
in accordance with their respective terms at no cost to BMI.

 

8.2          Survival
of Representations and Covenants of Buyers . Notwithstanding anything to the contrary contained herein and regardless
of any investigation by any BMI Indemnified Party, BMI, NuGene and the other BMI Indemnified Parties shall have the right to rely
fully upon the representations, warranties, covenants and agreements of the Buyer contained in this Agreement, the Merger Agreement
and in any agreement, instrument or other document delivered by Buyer or any of its representatives in connection with the transactions
contemplated by this Agreement and the Merger Agreement. Each representation, warranty, covenant and agreement of Buyer contained
herein and in the Merger Agreement shall survive the execution and delivery of this Agreement and the Closing, and shall thereafter
terminate and expire when a claim thereon is barred by the applicable statute of limitations (including extensions and waivers
thereof).

 

NUGENE/BMI

Business Transfer Indemnity Agreement

 

    	9

    	 

    

 

ARTICLE IX

TERMINATION; REMEDIES

 

9.1          Termination.
This Agreement may be terminated at any time prior to the Closing:

 

(a)          by
the mutual written consent of the parties hereto; or

 

(b)          by
Buyer, on the one hand, or by BMI, on the other hand, if the Closing shall not have occurred by December [31], 2014; provided,
however, that the right to terminate this Agreement pursuant to this Section 9.1(b) shall not be available
to any party or parties whose failure to fulfill any obligation under this Agreement shall have been the cause of, or shall have
resulted in, the failure of the Closing to occur on or prior to such date; or

 

(c)          by
BMI, upon the breach in any material respect of any of the representations and warranties of Buyer contained herein or the failure
by Buyer to perform and comply in any material respect with any of the agreements and obligations required by this Agreement to
be performed or complied with by Buyer, provided that such breach or failure is not cured within 30 calendar days of Buyer’s
receipt of a written notice from BMI that such a breach or failure has occurred.

 

9.2          Effect
of Termination. In the event of the termination of this Agreement in accordance with Section 9.1, this Agreement
shall become void and have no effect, with no liability on the part of any party or its Affiliates, directors, officers, employees,
stockholders or agents in respect thereof; provided, however that nothing herein shall relieve any party hereto from liability
for any breach of this Agreement.

 

9.3          Attorneys’
Fees. If BMI or Buyer shall bring an action against the other by reason of any alleged breach of any covenant, provision
or condition hereof, or otherwise arising out of this Agreement, the unsuccessful party shall pay to the prevailing party all reasonable
attorneys’ fees and costs actually incurred by the prevailing party, in addition to any other relief to which it may be entitled.

 

ARTICLE X

EXPENSES; CONFIDENTIALITY

 

10.1        Expenses
of Sale. Each of the parties hereto shall bear her or its own direct and indirect expenses incurred in connection with
the negotiation and preparation of this Agreement and the consummation and performance of the transactions contemplated herein
and therein.

 

10.2        Confidentiality.
Except in connection with any dispute between the parties and subject to any obligation to comply with (i) any Applicable
Law (ii) any rule or regulation of any Authority or securities exchange or (iii) any subpoena or other legal process
to make information available to the Persons entitled thereto, whether or not the transactions contemplated herein shall be concluded,
all information obtained by any party about any other, and all of the terms and conditions of this Agreement, shall be kept in
confidence by each party, and each party shall cause its stockholders, directors, officers, managers, employees, agents and attorneys
to hold such information confidential. Notwithstanding the foregoing this Agreement may be disclosed within and filed as an exhibit
to any filing made by the BMI with the SEC.

 

NUGENE/BMI

Business Transfer Indemnity Agreement

 

    	10

    	 

    

 

ARTICLE XI

NOTICES

 

11.1        Notices.
All notices, requests and other communications hereunder shall be in writing and shall be delivered by courier or other means of
personal service (including by means of a nationally recognized courier service or professional messenger service), or sent by
facsimile or mailed first class, postage prepaid, by certified mail, return receipt requested, in all cases, addressed to:

 

If to BMI:

 

Bling Marketing, Inc.

c/o
NuGene, Inc. 

720 Paularino Avenue

Costa Mesa, California 92626

Attention: Chief Executive Officer

  

If to Buyer:

 

Dena Kurland

150 West 46th Street

Suite 5R

New
York, New York 10036

 

 

With a copy (which shall
not constitute notice) to:

 

[           ]

 

All notices, requests
and other communications shall be deemed given on the date of actual receipt, delivery or refusal as evidenced by written receipt,
acknowledgement or other evidence of actual receipt or delivery to the address specified above. In case of service by facsimile,
a copy of such notice shall be personally delivered or sent by registered or certified mail, in the manner set forth above, within
three Business Days thereafter. Any party hereto may from time to time by notice in writing served as set forth above designate
a different address or a different or additional Person to which all such notices or communications thereafter are to be given.

 

NUGENE/BMI

Business Transfer Indemnity Agreement

 

    	11

    	 

    

 

ARTICLE
XII

MISCELLANEOUS

 

12.1        Further
Assurances. Each of the parties shall use its reasonable and diligent best efforts to proceed promptly with the transactions
contemplated herein, to fulfill the conditions precedent for such party’s benefit or to cause the same to be fulfilled and
to execute such further documents and other papers and perform such further acts as may be reasonably required or desirable to
carry out the provisions hereof and the transactions contemplated herein.

 

12.2        Modifications
and Amendments; Waivers and Consents. At any time prior to the Closing Date or termination of this Agreement, Buyer,
on the one hand, and BMI, provided that it has obtained the consent of NuGene, on the other hand, may, by written agreement:

 

(a)          modify
or amend the provisions of this Agreement;

 

(b)          extend
the time for the performance of any of the obligations or other acts of the other parties hereto;

 

(c)          waive
any inaccuracies in the representations and warranties made by the other parties contained in this Agreement or any other agreement
or document delivered pursuant to this Agreement; and/or

 

(d)          waive
compliance with any of the covenants or agreements of the other parties contained in this Agreement. However, no such waiver shall
operate as a waiver of, or estoppel with respect to, any subsequent or other failure. Whenever this Agreement requires or permits
a waiver or consent by or on behalf of any party hereto, such waiver or consent shall be given in writing.

 

12.3        Entire
Agreement. This Agreement (including any Schedules hereto) and the agreements, documents and instruments to be executed
and delivered pursuant hereto or referred to herein are intended to embody the final, complete and exclusive agreement among the
parties with respect to the purchase of the Jewelry Operations and related transactions; are intended to supersede all prior agreements,
understandings and representations written or oral, with respect thereto; and may not be contradicted by evidence of any such prior
or contemporaneous agreement, understanding or representation, whether written or oral.

 

12.4        Governing
Law and Venue.

 

(a)          This
Agreement is to be governed by and construed in accordance with the laws of the State of California applicable to contracts made
and to be performed wholly within the State of California, and without regard to the conflicts of laws principles thereof.

 

(b)          Any
suit brought hereon against Buyer or BMI, whether in contract, tort, equity or otherwise, shall be brought in the state or federal
courts sitting in Los Angeles, California, with the parties hereto hereby waiving any claim or defense that each such forum is
not convenient or proper. Each party hereby agrees that any such court shall have in personam jurisdiction over it, consents to
service of process in any manner authorized by California law, and agrees that a final judgment in any such action or proceeding
shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner specified by law.

 

12.5        Assignment.
This Agreement shall be binding upon, shall inure to the benefit of, and shall be enforceable by the parties hereto and their permitted
successors and assigns.

 

NUGENE/BMI

Business Transfer Indemnity Agreement

 

    	12

    	 

    

 

12.6        Counterparts.
This Agreement may be executed simultaneously in any number of counterparts, each of which shall be deemed an original of the party
or parties who executed such counterpart but all of which together shall constitute one and the same instrument. In making proof
of this Agreement it shall not be necessary to produce or account for more than one counterpart evidencing execution by each party
hereto. Delivery of an executed counterpart of a signature page to this Agreement or any Transaction Document by facsimile or electronically
shall be as effective as delivery of a manually executed counterpart of any such agreement.

 

12.7        Section
Headings. The section headings of this Agreement are for convenience of reference only and shall not be deemed to alter
or affect any provision hereof.

 

12.8        Severability.
In the event that any provision or any part of any provision of this Agreement shall be void or unenforceable for any reason whatsoever,
then such provision shall be stricken and of no force and effect. However, unless such stricken provision goes to the essence of
the consideration bargained for by a party, the remaining provisions of this Agreement shall continue in full force and effect,
and to the extent required, shall be modified to preserve their validity.

 

12.9        No
Third-Party Rights. Except as otherwise set forth in this Agreement, no rights or remedies under or by reason of this
Agreement shall be conferred on any Persons other than the parties hereto and their respective successors and assigns, nor is anything
in this Agreement intended to relieve or discharge the obligation or liability of any third Persons to any party to this Agreement,
nor shall any provision give any third Persons any right of subrogation over or action against any party to this Agreement.

 

12.10      Construction.
The language in all parts of this Agreement shall in all cases be construed simply, according to its fair meaning, and not strictly
for or against any of the parties hereto. Without limitation, there shall be no presumption against any party on the ground that
such party was responsible for drafting this Agreement or any part thereof.

 

12.11      Advice
of Counsel. Each party acknowledges that such party has consulted with or has had the opportunity to consult with and
be represented by independent counsel of such party’s own choice concerning this Agreement, and each party acknowledges that
such party has carefully read and fully understands this Agreement, is fully aware of the contents thereof and its meaning and
legal effect, and has entered into it free from coercion, duress or undue influence.

 

NUGENE/BMI

Business Transfer Indemnity Agreement

 

    	13

    	 

    

  

IN WITNESS WHEREOF,
the parties hereto have duly executed this Agreement as of the day and year first above written.

 

	 	BUYER:
	 	 
	 	/s/ Dena Kurland
	 	Dena Kurland
	 	 
	 	COMPANY:
	 	 
	 	BLING MARKETING, INC.,
	 	a Nevada corporation
	 	 
	 	By:	/s/ Ali Kharazmi
	 	 	 
	 	Name:	Ali Kharazmi
	 	 	 
	 	Title:	Chief Executive Officer

 

NUGENE/BMI Bus Transfer Indemnity Signature
Page

 

    	 

    	 

    

  

SCHEDULE 1

TO

Jewelry Operations Transfer and Indemnity
Agreement

 

RETAINED LIABILITIES

 

All loans, expenses, taxes, license fees,
liabilities and claims have been assumed by Buyer.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}]]